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Summary	  
The extensive use of fossil fuels has a severe influence on the environment. In order 
to reduce the dependency on these limited resources and to protect the environment 
substantial effort is being made to implement renewable resources. One part of this 
transition is to develop methods for sustainable production of chemicals, which can 
be achieved by microbial cell factories.  
The work presented in this PhD thesis elucidates the application of Pseudomonas 
putida as a microbial cell factory for production of the biosurfactant rhamnolipid. The 
rhamnolipid production was achieved by heterologous expression of the rhlAB oper-
on from Pseudomonas aeruginosa using a synthetic promoter library in P. putida. 
Since rhamnolipid production is associated with difficulties in conventional bioreac-
tors we have used biofilm encased P. putida to circumvent these problems. We show 
that biofilm can be used as a production platform for continuous production of rham-
nolipids. A method for quantitative and qualitative analysis of the produced rhamno-
lipids was developed based on ultra performance liquid chromatography combined 
with high resolution mass spectrometry. This enabled detection of low levels of 
rhamnolipids.  
The applicability of glycerol as a substrate was also investigated. Since glycerol is a 
poor substrate adaptive evolution was made in order to improve the capabilities of P. 
putida to proliferate on glycerol. The evolved lineages all had significantly increased 
growth rate, enhanced cell density and reduced lag phase. The genomic alterations 
were identified by genome sequencing and revealed parallel evolution. Glycerol was 
also shown to be able to support biofilm growth and as a result of this it can be used 
as an alternative substrate for producing biochemicals in conventional and biofilm 
reactors.  
The use of biofilm as a production platform and the usage of glycerol as a feedstock 
show the potential of using microbial cell factories in the transition toward sustaina-
ble production of chemicals. Particularly, the applicability of biofilm as a production 
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platform can emerge as a promising alternative for producing toxic biochemicals and 
for producing biochemicals which are difficult to cope in conventional bioreactors.  
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Dansk	  resume	  	  
Den stigende anvendelse af fossile brændstoffer har alvorlige konsekvenser for miljø-
et. For at reducere afhængigheden af disse begrænsende ressourcer, og for at beskytte 
miljøet, bliver der gjort en stor indsats for at implementere vedvarende ressourcer. Et 
bidrag til denne omstilling er udviklingen af bæredygtig produktion af kemikalier, 
hvilket kan opnås ved brug af mikrobielle celle fabrikker.  
Denne Ph.d. afhandling undersøger anvendelsen af Pseudomonas putida som en mi-
krobiel celle fabrik til fremstilling af det biologiske overfladeaktive stof (biosurfa-
cant) rhamnolipid. Produktionen af rhamnolipider blev muliggjort ved heterologt at 
udtrykke rhlAB operonet fra Pseudomonas aeruginosa ved hjælp af et syntetisk pro-
moter bibliotek i P. putida. Produktionen af rhamnolipider er forbundet med udfor-
dringer i traditionelle bioreaktorer, hvorfor vi har anvendt P. putida biofilm for at 
omgå disse komplikationer. I dette studie kan vi således vise at biofilm kan benyttes 
som en produktions platform til kontinuerlig produktion af rhamnolipider. Kvantitati-
ve og kvalitative undersøgelser af de producerede rhamnolipider blev foretaget ved 
hjælpe af en hertil udviklet metode, baseret på ultra højtydende væske kromatografi 
kombineret med høj resolution masse spektrometri. Den udviklede metode mulig-
gjorde detektion af små mængder af rhamnolipider.   
Anvendelsen af glycerol som et substrat blev også undersøgt i dette studie. Eftersom 
glycerol er kendt som et ringe substrat, lavede vi et adaptivt evolutions eksperiment 
med henblik på at optimere P. putidas evne til at formere sig på glycerol. De udvikle-
de stamme udviste et signifikant øget væksthastighed, øget celle densitet samt reduce-
ret lag fase. De bagvedliggende årsager til disse forbedringer blev undersøgt ved 
hjælp af genom sekventering som viste tydelige tegn på parallel evolution. Endvidere 
viser vi at glycerol kan benyttes til biofilm dannelse, og dermed anvendes som et al-
ternativt substrat til fremstilling af biokemikalier i både traditionelle og biofilm reak-
torer.  
Både anvendelse af biofilm og brugen af glycerol viser potentialet af mikrobielle cel-
le fabrikker til fremstilling af kemikalier på bærerdygtig vis. Anvendelse af biofilm 
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som et produktions platform fremstår særligt som et lovende alternativ til fremstilling 
af giftige og komplicerede biokemikalier der er vanskelige at håndtere i konventionel-
le bioreaktorer.  
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Chapter	  1	  	  
Introduction	  
During the last decades there has been an increased focus on human-induced envi-
ronmental changes and their consequences. This has given rise to a clear consensus 
on reducing the extensive usage of fossil fuels, since this can be traced to have a se-
vere impact on the environment (Mitigation, 2011). Additionally, the reservoirs of 
these resources are limited which furthermore necessitate a transition toward renewa-
ble feedstocks such as wind power, solar energy and organic material (biomass) 
(Scarlat et al., 2015, Ragauskas et al., 2006, Mitigation, 2011).  
One way of encountering the challenges is to use microorganisms as cell factories for 
production of biochemicals (Ragauskas et al., 2006). Microbial cell factories offer an 
alternative to the fossil fuels based production toward a sustainable production of 
chemicals, fuels and pharmaceuticals from renewable resources (Dai and Nielsen, 
2015). Although much research has been made in order to use microorganisms in sus-
tainable production several aspect still remains to be elucidated in order to reach a 
fossil fuel independent society (Zargar et al., 2015). Some of the faced challenges are 
the complex nature of metabolism, heterologous expression of enzymes, tolerance to 
toxic compounds and compounds which are challenging to produce in conventional 
setups. Despite of this, various biochemicals have been engineered with the potential 
for being realised at an industrial scale production (Feldman et al., 2011, Zhu et al., 
2014, Blank et al., 2012).  
Several considerations needs to be evaluated in order to chose the right organism for 
producing a biochemical. These considerations range from substrates and production 
conditions to the final biochemical to be produced. The host should be able to tolerate 
the synthesised biochemical and the metabolic pathway for producing the compound 
should exist in the host or it should be possible to introduce the necessary pathways 
by genetic engineering. Hence, knowledge and efficient genetic tools should be avail-
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able for manipulating the host (Keasling, 2010). The most widely used organism for 
production of biochemicals are Bacillus subtilis, Escherichia coli and Saccharomyces 
cerevisiae (Keasling, 2010).  
One group of organisms with not yet explored potential is Pseudomonas spp. This 
genus has species that have many catabolic and anabolic capabilities which are of 
particular interest for industrial applications (Poblete-Castro et al., 2012). Further-
more these bacteria have an inherent tolerance towards many compounds (such as 
solvents) which makes them favourable for industrial applications. Another desirable 
feature is their ability to grow in the sessile mode of growth called biofilm. By grow-
ing in surface-associated biofilms the cells become more resistant towards hostile 
compounds in their surroundings compared to their planktonic counterparts (Li et al., 
2006). Hence, these features of the biofilm mode of growth can be utilised to produce 
biochemicals that are detrimental for the cells at high concentrations.  
In the following chapters the various aspects of producing biochemicals will be pre-
sented. Firstly an alternative substrate, crude glycerol, will be presented (Chapter 2) 
followed by production of a promising biosurfactant rhamnolipids (Chapter 3). This 
will be based on employing Pseudomonas putida as the host (Chapter 4) for heterolo-
gous production of rhamnolipids in a biofilm (Chapter 5). The heterologous produc-
tion of rhamnolipids was achieved by employing a synthetic promoter library (Chap-
ter 6). These are the main topics of this PhD dissertation (Chapter 7). Following the 
conclusion and perspectives (Chapter 8) is the research article in Chapter 10. 
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Chapter	  2	  
Alternative	  feedstocks	  	  
The use of alternative feedstocks for production of biochemicals is of increasing in-
terest in order to reduce the production cost and to make biobased production more 
cost competitive (Posada et al., 2011, Johnson and Taconi, 2007). Lignocellulosic 
biomass and organic by-products, such as glycerol, are particularly interesting as they 
are low-cost feedstocks and do not give rise to the dilemma of diverting the food sup-
ply away from the human food chain. Although the use of alternative feedstocks is 
attractive and the use of inexpensive waste materials from industrial processes could 
reduce production cost, their use is challenging owing to the presence of several mi-
crobial inhibitors which affect the subsequent processing (da Silva et al., 2009). 
2.1	  	  	  	  	  Crude	  glycerol	  as	  an	  alternative	  substrate	  	  
One example of waste material is crude glycerol derived from the biodiesel produc-
tion. The use of biodiesel have increased during recent years as it can be used in con-
ventional diesel engines with little or no major modifications (Johnson and Taconi, 
2007). The challenge of using crude glycerol is the impurities present in the waste 
product together with the variation in composition depending on origin of production 
(Thompson and He, 2006, Hu et al., 2012). Although the composition and compo-
nents in batches differ the predominant impurities are methanol and sodium or potas-
sium residues from the transesterification process (da Silva et al., 2009). In addition 
to these compounds, heavy metals also adds on to the list of impurities (Fu et al., 
2015). In addition to these impurities, crude glycerol also contains free fatty acids 
which together with glycerol can serve as a carbon source (Fu et al., 2014, Fu et al., 
2015).  
In order to use waste glycerol as substrate the employed microorganism should be 
able to tolerate and cope with the present impurities to achieve a sufficient production 
Chapter 2 Alternative feedstocks 
 
PhD thesis by Vinoth Wigneswaran                                                                                               4 
setup. Otherwise a detoxification process may be needed which will increase the cost. 
One organism having a high inherent tolerance towards various inhibitory compounds 
is P. putida. This organism has been shown to be able to grow equally well in crude 
glycerol as in pure reagent grade glycerol (Fu et al., 2014, Fu et al., 2015). Hence, 
this organism is able to tolerate and circumvent the challenges there might be in using 
this alternative substrate without the requirement for making genetic engineering to 
get it to proliferate on crude glycerol.  
The impurities can however in some cases be beneficial. Since crude glycerol is di-
luted before use the concentration of the impurities decreases. Thus, in some cases the 
diluted impurities can be taken advantage of by serving as nutrients. It has been 
shown that addition of crude glycerol alone could sustain growth and the addition of 
Fe and Mg salts could together with crude glycerol restore growth of P. putida to the 
level obtained when supplementing with mineral salts (Verhoef et al., 2014).  
The use of crude glycerol as substrate has been investigated for production of poly-
hydroxyalkanoates (PHAs) used for manufacturing biodegradable plastics (Fu et al., 
2014, Fu et al., 2015). Fu et al. (2015) identified changes at the transcriptomic and 
proteomic level when they used crude glycerol although these changes did not give 
rise to an alteration in growth rate. In particular genes involved in inorganic ion 
transport and metabolism was elevated which correlated with the know impurities 
present in crude glycerol. 
Another example of using crude glycerol as the substrate for producing biochemicals 
is the production of p-hydroxybenzoate. Verhoef et al. (2014) investigated the effect 
of crude glycerol on production of p-hydroxybenzoate and growth of E. coli and P. 
putida. Surprisingly, they found a stimulating effect of crude glycerol on the perfor-
mance of P. putida rather than hampering the cells. In contrast, E. coli was severely 
hampered by the impurities although it was able to proliferate. Hence, the choice of 
organism is highly important on the outcome when using crude glycerol. 
Although the use of crude glycerol as a low cost feedstock is attractive when using P. 
putida as a microbial cell factory, the glycerol metabolism is not well known in P. 
putida. The use of glycerol is associated with both low growth rates and long lag 
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phase which is a major limitation in utilising glycerol (Nikel et al., 2014). Conducting 
adaptive laboratory evolution experiments could improve the glycerol utilisation as 
this approach has shown to be effective in improving substrate utilisation (Wisselink 
et al., 2007, Meijnen et al., 2008).  	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Chapter	  3	  
Biosurfactant	  
The transition toward a sustainable green production of chemicals is a process being 
initiated over the last decades. There is a general agreement that a transition towards 
sustainable synthesis of chemicals is a necessity to preserve the environment. The de-
velopment of sustainable bioprocesses for replacing the conventional petrochemical 
based products is however a challenging task. Although the transition toward bi-
obased synthesis of chemicals is very appealing their commercial application is fac-
ing a major obstacle – the economy (Bozell and Petersen, 2010). However, the ad-
vances made in biotechnology combined with increased awareness among the con-
sumers have promoted the search for more environmental friendly alternatives to the 
conventional petrochemical based chemicals (Banat et al., 2000).  
One class of chemicals, which have gained much attention in this transition, is surfac-
tants (Banat et al., 2000, Muller et al., 2012). Surfactants are surface active molecules 
able to interact between aqueous and nonaqueous interfaces. This is mediated by the 
amphiphilic nature of the molecules consisting of a hydrophilic head and a hydropho-
bic tail. This structure increases the aqueous solubility of hydrophobic liquids by re-
ducing the surface/interface tension at the air-water and water-oil interface (Haba et 
al., 2003). This property makes them act as detergents, emulsifiers, foaming agent 
and wetting agent. Hence, the broad applicability of this group of chemicals also 
makes them an important and widely used class of chemicals in industry, agriculture, 
food, cosmetic and pharmaceutical applications (Muller et al., 2012, Henkel et al., 
2012).  
A substantial amount of research has been made in relation to produce surfactants by 
microorganisms – referred to as biosurfactants. The increased focus is supported by 
the fact that biosurfactants possess considerable advantages compared to their chemi-
cal counterparts. The petroleum derived surfactants are usually toxic and rarely de-
graded by microorganisms and therefore constitute a potential source of pollution. In 
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contrast, biosurfactants are more environmental friendly by being less toxic, and bio-
degradable. Furthermore, they have high surface activity, are more structurally di-
verse, and can be produced from renewable products (Haba et al., 2003, Sousa et al., 
2012, Banat et al., 2010). These features also make them candidate for new applica-
tions in bioremediation of hydrocarbons from contaminated soil and water, heavy 
metal removal, soil washing and oil spills (Costa et al., 2010, Urum and Pekdemir, 
2004, Mulligan and Wang, 2006). 
Microbial surfactants are produced by many bacteria and fungi (Morita et al., 2007, 
Cavalero and Cooper, 2003, Moya Ramirez et al., 2015, Banat et al., 2010). A range 
of different biosurfactants can be produced depending on the organism and culture 
conditions used. The biosurfactants are classified on the basis of their chemical struc-
ture into five groups. These are glycolipids, lipopeptides, fatty acids, phospholipids, 
and polymeric biosurfactants (Ward, 2010). The differences in the physiochemical 
properties of a biosurfactant will make it more or less suitable for the application of 
interest.  
The production of biosurfactants are not yet cost competitive in comparison to their 
synthetic counterparts. Hence, for biosurfactants to replace synthetic surfactants the 
cost of raw materials and process should be minimised. Various renewable substrates 
have been considered in this regard such as industrial waste. Some of these are olive 
oil mill effluent produced from olive oil extraction, waste cooking oil and glycerol 
from biodiesel production (Mercade et al., 1993, Moya Ramirez et al., 2015, Lan et 
al., 2015, Sousa et al., 2012). In addition to reduce the cost for substrates the use of 
waste materials also provide added value for these products which otherwise would 
be discarded and constitute an environmental disposal problem (Henkel et al., 2012).  
3.1	  	  	  	  	  Rhamnolipids	  –	  a	  promising	  biosurfactant	  	  
One of the biosurfactants that has gained a lot of attention is the glycolipid rhamno-
lipid. Rhamnolipids are a group of biosurfactants that have been know for many 
years. But during the last decades their potential have been acknowledged and their 
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wide range of applications have fuelled additional interest. Based on the recent publi-
cations and patents, rhamnolipids is the most investigated glycolipid as seen in Figure 
1.  
 
Figure 1 – The increasing interest in biosurfactants. (A) The number of worldwide patents available 
through European Patent Office. (B) Number of publication according to ISI Web of Science for the listed 
search terms (Muller et al., 2012).  
Rhamnolipids were first described by Jarvis and Johnson (1949) in Pseudomonas ae-
ruginosa. Similar to other surfactants, rhamnolipids are amphiphilic molecules com-
posed of a hydrophilic part represented by rhamnose and a hydrophobic part repre-
sented by fatty acids (Figure 2). The number of rhamnose residues, fatty acid length 
and saturation vary depending on the employed strain and growth conditions (Deziel 
et al., 1999).  
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Figure 2 – Outline of the rhamnolipids. The gray part of the structure is the varying part of the rhamno-
lipids that differ in the different congeners. The numbers indicate the length of the fatty acid side chain.  
3.2	  	  	  	  	  Biosynthesis	  of	  rhamnolipids	  	  
In P. aeruginosa the most predominant congener is di-rhamnolipid L-rhamnosyl-L-
rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate (Rha-Rha-C10-C10) followed by 
the mono-rhamnolipid L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate (Rha-
Rha-C10-C10) (Deziel et al., 2000). However, other combinations of rhamnose and 
fatty acids are possible (Deziel et al., 1999, Rudden et al., 2015).  
Three enzymes are mediating rhamnolipid synthesis in P. aeruginosa (Figure 3). The 
first step is the synthesis of rhamnose and fatty acid precursors. The lipidemic precur-
sor is coming from de novo synthesis of fatty acids and the immediate precursor 3-(3-
hydroxyalkanoyloxy)alkanoate (HAA) is synthesised by rhlA (Deziel et al., 2003, 
Zhu and Rock, 2008). Glucose is converted into dTDP-L-rhamnose which together 
with HAA are the substrates of RhlB for synthesising mono-rhamnolipids (Rahim et 
al., 2001). The di-rhamnolipids are synthesised by adding another rhamnose residue 
to the mono-rhamnolipids by rhlC (Rahim et al., 2001).  The rhlA and rhlB genes 
necessary for synthesising mono-rhamnolipids constitute an operon (Pearson et al., 
1997, Ochsner et al., 1994a) while rhlC is placed in another part of the genome 
(Rahim et al., 2001).  
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Figure 3 – Rhamnolipid biosynthesis pathway. The enzymatic steps required for producing rhamnolipids 
are shown. P. aeruginosa contains all the required genes for rhamnolipid synthesis. In P. putida the rhlAB 
genes needs to be introduced (Wittgens et al., 2011).  
The biosynthesis of rhamnolipids is highly regulated in P. aeruginosa. Expression of 
the rhlAB operon is under quorum sensing control and also influenced by multiple 
environmental factors such as availability of phosphate, nitrate, ammonium and iron 
(Ochsner et al., 1994b, Ochsner and Reiser, 1995, Pearson et al., 1997, Mulligan et 
al., 1989, Guerra-Santos et al., 1986, Mulligan and Gibbs, 1989, Deziel et al., 2003).  
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The pathways for the precursors exist in various bacteria as rhamnose and the fatty 
acids are provided from glucose and de novo synthesis of fatty acids respectively 
(Rahim et al., 2000, Aguirre-Ramirez et al., 2012, Zhu and Rock, 2008). Hence, the 
basis for a heterologous production of rhamnolipids exists in various organisms. Het-
erologous production of rhamnolipid has been achieved in recombinant E. coli, P. 
fluorescens, P. oleovorans and P. putida (Zhu and Rock, 2008, Ochsner et al., 1995, 
Wittgens et al., 2011) by introducing the P. aeruginosa rhlAB operon. A heterologous 
synthesis of rhamnolipids has many advantages compared to using the native host (P. 
aeruginosa). For example, it will relieve the biosynthesis from quorum sensing regu-
lation and from the influence of external factors. This enables the possibility of engi-
neering and modulating the biosynthesis without being obligated to consider the in-
herent control of the organism.  
3.3	  	  	  	  	  Methods	  for	  detecting	  rhamnolipids	  
Different methods can be used for detecting rhamnolipids. These methods range from 
simple indirect methods based on physical properties of rhamnolipids, such as altera-
tion in interfacial tension, to more advanced methods based on mass spectrometry. In 
between these are colorimetric methods which are based on reactions between the 
rhamnose residue and a coloured chemical compound that can be quantified (Heyd et 
al., 2008). Examples of colorimetric methods are the anthrone and orcinol assays 
(Hodge, 1962, Chandrasekaran and Bemiller, 1980). These assays have been com-
monly used in various studies (Cha et al., 2008, Pamp and Tolker-Nielsen, 2007, 
Mata-Sandoval et al., 1999). The benefit of these methods is that they provide a quick 
and simple quantification without the need for expensive equipment. The disad-
vantage of these methods is the lack of discrimination of the different rhamnolipid 
congeners. Hence, they do not provide a precise determination of the different conge-
ners but rather a measure of the combined quantity. Furthermore, low level of rham-
nolipids cannot be detected by these assays.  
For precise determination and quantification of rhamnolipid congeners mass spec-
trometry (MS) could be employed. Mass spectrometry is often coupled with high per-
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formance liquid chromatography (HPLC) in order to separate the constituents (Deziel 
et al., 2000). Hence, by HPLC the sample constituents are separated followed by 
identification and quantification by MS. The identification of the different rhamno-
lipid congeners is based on their elemental composition. Structural isomers, such as 
Rha-C10-C8 and Rha-C8-C10, can however not be discriminated by this method. This 
can be made by MS/MS on the basis of the fragmentation pattern (Rudden et al., 
2015). Compared to the abovementioned methods HPLC-MS provide much more in-
formation on the rhamnolipid composition and can be used to detect much lower 
quantities. However, this method requires advanced instrumentation and the follow-
ing data analysis is more cumbersome.  
The importance of discriminating the rhamnolipid congeners have been shown to be 
important for production of rhamnolipids as the ratio between rhamnolipid congeners 
can change during cultivation (Muller et al., 2010). This is of particular importance 
when using P. aeruginosa as the production host since this strain produces a range of 
different rhamnolipid congeners (Deziel et al., 1999, Rudden et al., 2015). Hence, for 
investigating such changes advance methods such as HPLC-MS are crucial, as the 
composition of congeners will have an effect of on the physiochemical properties of 
the resulting rhamnolipid mixture.  
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Chapter	  4	  
Pseudomonas	  spp	  and	  their	  capabilities	  	  
Different organisms are being used as industrial workhorses. The choice highly de-
pends on the knowledge of the organism and the methods available for genetic ma-
nipulations. E. coli is one of the most studied organisms, and for this reason it is one 
of the most important microbial cell factory. The advances made in biotechnology 
during the last decades have opened up possibilities for the use of alternative organ-
isms that were not previously considered as suitable to be employed as microbial cell 
factories. Some of the new organisms are from the metabolically versatile genus 
Pseudomonads (Poblete-Castro et al., 2012).  
Pseudomonads are Gram-negative bacteria belonging to Proteobacteria. They are 
ubiquitous due to their versatility which enable them to grow in various habitats. The 
members of this genus have shown to possess a remarkable inherent capacity to thrive 
in hostile environments and adapt to these conditions which is one of the reasons for 
their wide prevalence. For instance the opportunistic pathogen P. aeruginosa have 
been able to cope with the challenging conditions present in the lungs of cystic fibro-
sis patients (Folkesson et al., 2012). Here they are constantly challenged by the im-
mune system as well as the extensive administration of antibiotics to eradicate their 
presence. Despite this, P. aeruginosa have managed to develop systems by which 
they have been able to evade the obstacles (Folkesson et al., 2012). Another example 
is P. putida which is able to thrive in highly contaminated habitats and have devel-
oped systems to degrade various toxic compounds (Faizal et al., 2005).  
Although not all of these features are beneficial they exemplify some of the remarka-
ble capabilities of this genus. Owing to these inherent abilities, these organisms have 
gained increasing attention in being used as microbial cell factories.  
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4.1	  	  	  	  	  Pseudomonas	  putida	  –	  a	  versatile	  microorganism	  	  
One of the new organisms being considered as a promising industrial host is P. 
putida. It is one of the best studied species of the genus Pseudomonads and is a strain 
gaining increasing attention for is broad metabolic versatility (Poblete-Castro et al., 
2012). This strain exhibits a great metabolic potential by having various chromoso-
mally encoded pathways for catabolising a vast range of compounds (Nelson et al., 
2002). Its ability to adapt to varying physiochemical conditions make them highly 
ubiquitous (Faizal et al., 2005).   
A commonly used strain is P. putida KT2440 which is a TOL plasmid cured deriva-
tive of P. putida mt-2 (Bayley et al., 1977, Bagdasarian et al., 1981). The sequencing 
of the P. putida KT2440 genome (Nelson et al., 2002) has revealed the genomic rep-
ertoire of the organism, provided new insight into the inherent capabilities and facili-
tated genetic engineering of the organism. The use of P. putida KT2440 is interesting 
in an industrial setting as the strain has been approved as a biological safety strain 
(Federal Register, 1982). 
The metabolic versatility of P. putida is very useful in using alternative feedstocks 
(Figure 4). The use of crude glycerol from the biodiesel production has for instance 
been shown possible without being obligated to make genetic modifications (Fu et al., 
2014). Although P. putida possesses the ability to assimilate various substrates it 
cannot use pentose sugars. This would have been great as lignocellulosic biomass 
contains pentose sugars such as xylose and arabinose (Isikgor and Becer, 2015). 
However, P putida can be engineered to utilise both xylose and arabinose (Meijnen et 
al., 2008).  
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Figure 4 – The application of P. putida as a cell factory for biobased production of various biochemicals 
from renewable substrates (Poblete-Castro et al., 2012).  
The inherent tolerance of P. putida has been shown to be very beneficial in producing 
biochemicals (Poblete-Castro et al., 2012, Wittgens et al., 2011). Compared to the 
more traditional organisms such as E. coli, P. putida has been proved to be able to 
cope with the impurities found in crude glycerol from the biodiesel production 
(Verhoef et al., 2014). This is useful as it enables the use of crude glycerol without 
having to detoxify the feedstock. 
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4.2	  	  	  	  	  Industrial	  application	  of	  P.	  putida	  
The inherent capabilities of P. putida are not only beneficial in using alternative feed-
stocks but are also very interesting for producing biochemicals (Figure 4). This was 
exemplified in the biosynthesis of rhamnolipids by Wittgens et al. (2011). In this 
study they evaluated some of the commonly used microorganisms such as E. coli, B. 
subtilis, C. glutamicum and P. putida for determining the best suited organism for 
producing rhamnolipids. The presence of high concentrations of rhamnolipids de-
creased the growth rate of these organisms. In general, the Gram-positive organisms 
were more affected than the Gram-negative organisms. In particular P. putida exhib-
ited a clear advantage compared to its competitors. Hence, the inherent tolerance of 
P. putida to rhamnolipids is highly desirable as it negates the need for cumbersome 
genetic modifications to enable it to cope with the compound it is synthesising.  
As well as its use in rhamnolipid production P. putida has also been useful for mak-
ing the polymers polyhydroxyalkanoates (PHA) which is a large class of polyesters. 
Depending on the cultivation conditions, different PHA can be synthesised. Based on 
the knowledge of the metabolic pathways, genetic engineering can be conducted in 
order to redirect the production toward the compound of interest (Wang et al., 2011).   
The abovementioned examples are just some of the biochemicals which can be pro-
duced by P. putida (Poblete-Castro et al., 2012). The advances made in genetic engi-
neering of P. putida have been pivotal in enabling these modifications to be effectu-
ated and thereby the use of P. putida for the production of biochemicals. The inherent 
tolerance of P. putida offers an excellent starting point for suppressing the hurdles of 
using and producing toxic chemical compounds of natural or heterogeneous origin.  
The tolerance and resistance towards chemicals can further be extended if the con-
ventional mode of growth in planktonic cultures is replaced by the sessile mode of 
growth in biofilm. This mode of growth is associated with increased tolerance to-
wards toxic compounds and has been shown to withstand much more harsh condi-
tions than their planktonic counterparts (Li et al., 2006).  
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Chapter	  5	  
Biofilm	  
In nature most bacteria are found in structured surface associated sessile communities 
called biofilms (Costerton et al., 1995). Biofilm consist of microbial cells embedded 
in a self-produced matrix consisting of different types of biopolymers known as ex-
tracellular polymeric substances (EPS). The EPS has multiple roles. In addition to 
providing structural support for the protruding biofilm, it is involved in immobilising 
biofilm to the surface, providing cohesiveness to the biofilm as well as enhance bio-
film resistance to environmental stress (Costerton et al., 1995, Drenkard and Ausubel, 
2002). Thus, the EPS provides a protective environment for the microbial cells from 
their surroundings.  
The ubiquitous and protective nature of biofilm makes them a major challenge in var-
ious situations and make biofilm difficult to eradicate from unwanted settings – 
whether it is in the health care system or in industrial settings (Costerton et al., 1999). 
In the health care system, infections coursed by microbial biofilm are a major chal-
lenge owing to their resistance towards antimicrobial agents (Hall-Stoodley et al., 
2004, Hoiby et al., 2010). In industrial settings, the presence of biofilm in pipelines 
and fermenters result in fluctuation in productivity and thereby hamper stable produc-
tion (vellaisamy Kumarasamy and Maharaj, 2015). Similar hurdles of biofilm settling 
also have implications in the food industry (Winkelstroter et al., 2014). Hence, bio-
films are commonly encountered in our everyday life and cause challenges in various 
settings.  
Although the first observation of biofilm was made a long time ago (Zobell and 
Anderson, 1936) the observations were not followed up until several decades later 
(Costerton et al., 1978). The realisation of the widespread nature of biofilm, however, 
increased the research into elucidating the complexity of biofilm formation.  
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Lately, there has been an increased interest in the use of biofilms as a production plat-
form for producing biochemicals. In this way, some of the abovementioned features 
have been exploited. For instance the increased tolerance towards various compounds 
could be taken advantage of for the production of toxic biochemicals or for the use of 
alternative feedstocks. Furthermore, the growth on surfaces offers other opportunities 
and production setups than the conventional bioreactor systems.  
5.1	  	  	  	  	  Considerations	  associated	  with	  exploiting	  biofilm	  	  
The increasing knowledge on biofilm biology has enabled the use of biofilm as a pro-
duction platform. Currently most biological processes are made by microbial cells 
suspended in liquid media in batch or fed-batch cultures that are not reused but a con-
tinuous production of biochemicals in a biofilm offers interesting alternatives.  They 
are potentially more cost effective than batch cultivation owing to reduced downtime 
in reactor preparation, long term activity and cleaning (Rosche et al., 2009). A con-
tinuous production for several months without the need to interrupt the process and 
the resistance to external interruption make them even more interesting (Li et al., 
2013, Rosche et al., 2009, Gross et al., 2007). Biofilm is self-renewable, has high cell 
density and it has a higher intrinsic tolerance against toxic compounds than their 
planktonic counterpart (Gross et al., 2010, Li et al., 2006). Biofilm-based production 
has also been shown to be more robust in relation to contaminants. A contamination 
in the feedstock showed to have no effect on the biofilm reactor performance and on 
microbial composition (Li et al., 2013, Weuster-Botz et al., 1993). The high number 
of cells in the biofilm combined with continuous wash out of cells probably prevented 
the establishment of the contaminating organism. 
The long time viability of biofilm can however also be a challenge. During long time 
cultivation, changes can occur in metabolic activity which can ultimately affect the 
production (Li et al., 2013). Furthermore, it is known that cells growing in a biofilm 
have a lowered metabolic activity than their planktonic counterparts (Sternberg et al., 
1999). The selection of biochemicals for synthesis should therefore be carefully de-
termined in order to make a prudent choice. This could be a biochemical whose syn-
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thesis is growth independent. An example of this is rhamnolipids (Wittgens et al., 
2011). The production of rhamnolipids is of particular interest as the reduced meta-
bolic activity in a biofilm should not affect the biosynthesis and based on a metabolic 
network analysis, growth should be minimised in order to achieve high yields 
(Wittgens et al., 2011). Hence, this should result in a highly desirable combination of 
the parameters of interest.  
The complex and dynamic nature of biofilm is a concern in utilising biofilm. During 
cultivation the biofilm embedded cells will be in different physiological stages as 
they grow and disperse as well as undergo phenotypic changes (Sternberg et al., 
1999, Sauer et al., 2002, Stewart and Franklin, 2008, Werner et al., 2004, Gross et al., 
2010). This can lead to genetic instability or course variations in metabolic activity 
resulting in fluctuations in productivity or quality (Li et al., 2013). The ability to con-
trol growth is also crucial in order to avoid clogging and the resulting downtime. 
Mass transfer to maintain sufficient substrate distribution as well as to remove poten-
tial toxic or inhibiting products can also be challenging (Gross et al., 2010, Gross et 
al., 2007). 
5.2	  	  	  	  	  Examples	  of	  biofilm	  as	  the	  production	  platform	  
To date, biofilm is primarily used in bioremediation for treatment of wastewater 
(Judd, 2008). The use of biofilm as a microbial biocatalyst for producing biochemi-
cals has been exemplified in various studies exhibiting its potential (Rosche et al., 
2009). The use of biofilm in producing bulk chemicals has been reported sporadically 
during the last decades, for example lactic acid, ethanol, and butanol (Ho et al., 1997, 
Demirci et al., 1997, Qureshi et al., 2004). Lately the applicability of biofilm in bio-
synthesis and biotransformation has also been reported for fine chemicals (Li et al., 
2013, Li et al., 2006, Gross et al., 2010, Gross et al., 2007). The use of biofilm as a 
biocatalyst is of particular interest in producing biochemicals which are challenging 
in conventional cultivation setups, e.g. biosurfactants. 
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Different approaches have been made in order to determine a suitable design for cul-
tivation of biofilm for producing biochemicals. This has involved various reactor de-
signs, materials and cultivation designs for determining an optimal solution for deal-
ing with the encountered challenges (Li et al., 2006). The choice highly depends on 
the organism and the synthesising compound of interest. However, the cultivation 
material is crucial for establishment of biofilm. The surface properties of the material 
determine if the bacteria are able to get established on the surface (Qureshi et al., 
2005).  
5.3	  	  	  	  	  Methods	  for	  investigating	  biofilm	  
Different methods can be used for investigating biofilms. For visualisation of colony 
morphology and production of biofilm EPS, agar plates containing Congo red dye can 
be used (Friedman and Kolter, 2004). For fast and quantitative analysis, the crystal 
violet assay is commonly used (O'Toole and Kolter, 1998). In this assay, the cells are 
cultivated in microtiter plates and surface attached biofilm is stained and quantified 
by crystal violet. For following biofilm development in situ, a frequently used method 
is flow cell technology combined with confocal laser scanning microscopy (Pamp et 
al., 2009). By employing fluorescent reporter proteins or staining, organisms can be 
visualised and the biofilm development, dynamics, gene expression, imposed pertur-
bations and spatial organisation can be investigated in real time without disrupting the 
biofilm. The flow system used in our laboratory is depicted in Figure 5. The medium 
flow through the system is aided by the pump. The bubble traps capture any air bub-
bles in order to avoid disruption of the biofilm. The cells are cultivated in the flow 
channels on glass cover slides. The system can be assembled in various setups for 
achieving different growth conditions as well as for withdrawing samples for further 
analysis. A protocol for the procedure has been described by Tolker-Nielsen and 
Sternberg (2011) 
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Figure 5 – Biofilm flow cell system. The media is continuously pumped through the system. The media pass 
through bubble traps to avoid air in the flow chambers. The cells are cultivated in the flow channels. The 
connectors enable various assembly possibilities for media combinations and for sample collection (Weiss 
Nielsen et al., 2011).  
 	  
Chapter 6 Gene modulation 
 
PhD thesis by Vinoth Wigneswaran                                                                                               22 
Chapter	  6	  
Gene	  modulation	  	  
To have an efficient heterologous biosynthesis of a compound the necessary genes 
need to be expressed at a suitable level in the heterologous host. This is a necessity in 
order to prevent disrupting, interfering or severely hampering the host cell.  Gene 
functionality and activity can be changed and manipulated in many ways. This can 
for instance be done by modulating transcription and translation levels. For example  
promoters (Nevoigt et al., 2006), Shine-Dalgarno sequences (Bonde et al., 2016) and 
transcription factors (Cox et al., 2007) can be manipulated.  
Of the different possibilities for modulating gene expression, the use of promoters has 
been employed for many decades. (Reznikoff et al., 1969). In many cases, gene func-
tion has primarily been investigated by two extreme conditions – gene overexpression 
or gene inactivation. These conditions only provide limited information about the 
genes’ effect on phenotypes or metabolic pathways. For metabolic optimisation, tun-
ing of promoter activities is of utmost importance, as alterations may have an adverse 
effect on cells when using the all or nothing approach (Mijakovic et al., 2005). Fur-
thermore, these approaches make it challenging, if not impossible to explain small 
effects and metabolic perturbations that will be masked by the severe disturbances the 
drastic changes may result in. One strategy to encounter these constraints is to find 
native promoters of different strengths. However, the use of an endogenous promoter 
has its limitations as it may be subjected to regulation. Moreover, this approach is 
very time consuming to carry out.  
In recent years, the use of promoter libraries to make metabolic optimisation of vari-
ous pathways has become widely used. These have been designed for different organ-
isms including E. coli and S. cerevisiae (Cox et al., 2007, Nevoigt et al., 2006). With-
in these examples the native promoter was mutated in order to get promoters of vari-
ous strengths. This enables fine-tuning of gene expression for the manipulation of 
pathways and for producing biochemicals.  
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6.1	  	  	  	  	  Synthetic	  Promoter	  Library	  
One easy and fast approach of making promoters of various strengths is by employing 
the Synthetic Promoter Library (SPL) technology (Jensen and Hammer, 1998, Solem 
and Jensen, 2002). This method is based on the fact that some bases in a promoter 
sequence are more important than others when determining the strength of a promot-
er. Hence, by preserving some bases and randomising the surrounding bases, the 
promoter strength can be varied. The SPL technology can be used for creating both 
constitutive promoters as well as inducible promoters (Rytter et al., 2014). Constitu-
tive promoters should be made in such a way that they provide a constant expression 
through the growth of the organisms. One example is the use of rRNA promoters for 
constitutive expression as these are some of the strongest promoters (Rud et al., 
2006). Inducible promoters can also be made into promoter libraries by incorporating 
an operator or activator binding sites (Rytter et al., 2014). In this case, the promoters 
should exhibit strong control of gene expression and respond willingly to their chem-
ical signal.  
6.1.1	  	  	  	  	  Designing	  a	  synthetic	  promoter	  library	  
Synthetic promoter libraries are based on the importance of -35 and -10 consensus 
sequences and the spacer region (Lodge et al., 1990, Jensen and Hammer, 1998). 
Jensen and Hammer (1998) showed that alteration in the -35 and -10 consensus se-
quences or in the spacer sequence separating these sequences results in weak promot-
ers. Hence, the association of the consensus sequences to their surroundings is pivotal 
in determining the promoter activity. By alternating the adjacent bases the promoter 
strength can be changed.  
Based on this knowledge Solem and Jensen (2002) made an easy method for making 
SPLs by adding the SPL to the primers used for amplifying a gene of interest (GOI). 
Thereby the SPL can be created by a single PCR step to obtain SPL preceding GOI. 
By employing a reporter gene placed downstream of the SPL the activity of the ob-
tained promoter can be determined. Some examples of reporter genes are lacZ (β-
galactosidase), gusA (β-glucuronidase), lux (luciferase) and gfp (green fluorescent 
protein) (Solem and Jensen, 2002, Nevoigt et al., 2006). By placing GOI between 
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SPL and the reporter gene the expression of GOI could be determined. This has been 
made in various studies in which the correlation was seen to be linear (Hansen et al., 
2009, Solem and Jensen, 2002, Nevoigt et al., 2006). The SPL can also be used for an 
operon. In this case, the individual gene expression levels can be changes equally for 
both genes (Solem and Jensen, 2002).  
The SPL technology has a natural selection system incorporated within, as only the 
strains with viable expression will proliferate. Therefore, in case the expression levels 
are too high these promoters will naturally be excluded from the library. If an inter-
mediate strain, such as E. coli, is used in the construction it may have an effect on the 
SPL, as the intermediate strain may not be able to cope with the expressed GOI, for 
instance if the product is toxic to E. coli but not for the intended host. Nonetheless a 
strong overexpression of a non-toxic protein can also be lethal. In E. coli, competition 
for the ribosomes reflected in a decrease in growth rate and ultimately resulted in cell 
death (Dong et al., 1995).   
The SPL technology can be used for many different organisms (Solem and Jensen, 
2002). The same promoter library can however not necessarily be used in different 
organisms. Strong promoters made in the Gram-positive bacterium L. lactis did not 
result in high expression in the Gram-negative bacterium E. coli, although the pro-
moter was functional (Jensen and Hammer, 1998). This is likely to be owed to differ-
ences in recognition and preference of promoters in these organisms. However, in 
some cases, the differences in promoter activity is limited as has been shown for P. 
aeruginosa and E. coli (Lodge et al., 1990). This could be a consequence of both or-
ganisms being Gram-negative.  
 
6.1.2	  	  	  	  	  Construction	  of	  a	  synthetic	  promoter	  library	  	  
When constructing a SPL of strong promoters, the library can be based on rRNA 
promoters (Rud et al., 2006). Since promoters can be organism-specific they should 
preferably be based on functional promoters from the organism of interest. Following 
an alignment of the determined promoters the consensus sequence can be found and 
the -35 and -10 consensus sequence determined (Figure 6A). In this example the 
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promoters from P. putida and P. aeruginosa were employed for determining a SPL 
sequence which can be used in both organisms. Depending on the desired variability 
in SPL, the consensus sequences can be preserved or be doped. The surrounding ba-
ses should be randomised to provide variation of promoter strength (Figure 6B). The 
sequence stated in Figure 6B constitutes the SPL and can be added to primers used 
for amplification of GIO.  
 
Figure 6 – Design of a synthetic promoter library. (A) The rRNA promoter sequences from P. putida and P. 
aeruginosa have been aligned and the consensus sequence determined. Based on the alignment, a promoter 
sequence can be made as illustrated in (B). The -35 and -10 consensus sequences were preserved and the 
surrounding bases randomised for modulating the promoter strength. The consensus sequences can howev-
er also be randomised or doped in order to increase the variability of promoter strengths in the library. The 
consensus sequences are highlighted in pink boxes.  
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Chapter	  7	  
Present	  investigation	  
7.1	  	  	  	  	  Rhamnolipid	  production	  using	  biofilm	  as	  the	  production	  platform	  	  
To produce rhamnolipids at an industrial scale, it is not optimal to use an opportunis-
tic pathogen, which would be the case if P. aeruginosa is used. Hence, if the biosyn-
thetic pathway could be moved to another safe organism the concerns about patho-
genicity can be evaded. However, several considerations need to be made in order to 
choose the right organism. The organism should be able to produce rhamnolipids at 
high concentrations, either natively or be engineered to do so, and be able to tolerate 
high concentrations of rhamnolipids. In case the pathway is transferred for heterolo-
gous production, the growth phase dependent production and quorum sensing regula-
tion should be relieved when possible.  
In this PhD study, we wanted to make a proof of concept of using biofilm encased P. 
putida as a production platform for producing rhamnolipids (Paper 1). Rhamnolipids 
were chosen as the compound of interest since they have been shown as a promising 
alternative to the conventional surfactants (cf. chapter 3.1). Furthermore, since rham-
nolipids are biosurfactants they incur major challenges during production via the con-
ventional fermentation setup owing to foam production (Muller et al., 2010, Reiling 
et al., 1986, Urum and Pekdemir, 2004). Our hypothesis is that by using biofilm as a 
production platform these obstacles can be counteracted. Furthermore, since rhamno-
lipids have shown to hamper growth they also serve as a model compound for pro-
ducing toxic biochemicals. The use of both P. putida and biofilm offer a unique com-
bination of a production host possessing an immeasurable inherent metabolic capabil-
ity and the ability to tolerate various compounds combined with the use of biofilm 
which is known for its high robustness towards external challenges (cf. chapter 4 and 
5). 
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Several surfactants have been shown to interfere and disrupt biofilm formation of var-
ious organisms. The surfactant can act on the biofilm by several means, such as anti-
microbial agents, by disrupting biofilm and by degrading matrix components. The 
biosurfactants sophorolipids and rhamnolipids have shown to exhibit antimicrobial 
activity against both Gram-positive and Gram-negative bacteria (Diaz De Rienzo et 
al., 2016a). They can also act as an anti-adhesive agent and exhibit biofilm disruptive 
abilities resulting in an earlier onset of biofilm detachment (Boles et al., 2005, Irie et 
al., 2005, Diaz De Rienzo et al., 2016b). This is likely to be effectuated by degrading 
the components of the biofilm matrix as rhamnolipids can course release of lipopoly-
saccharides (Al-Tahhan et al., 2000). The biofilm matrix may then be destabilised by 
high levels of rhamnolipids. In P. aeruginosa the rhamnolipid production has been 
shown to be involved in structural organisation of the cells. This was mediated by cell 
motility as rhamnolipid deficient cells had changed biofilm morphology (Pamp and 
Tolker-Nielsen, 2007). Based on these studies we suspected that a heterologous ex-
pression of rhamnolipids would have an effect on the biofilm capabilities of P. 
putida. To clarify this and to investigate the alterations the biosynthesis of rhamno-
lipids can have on a heterologous host, we developed a Synthetic Promoter Library, 
which could reveal the implications of producing rhamnolipids and for obtaining an 
expression which is not influenced by any inherent regulatory systems (cf. chapter 
6.1).  
For detection of the produced rhamnolipids, we developed a method based on ultra 
performance liquid chromatography combined with high resolution mass spectrome-
try. This method enabled detection of small quantities of rhamnolipids, as a continu-
ous production in a biofilm will result in lower titers than in batch cultivation. The 
method also enables the detection and characterisation of the different rhamnolipid 
congeners produced by the engineered strains (cf. chapter 3.3).  
The employment of biofilm as the production platform for rhamnolipids in Paper 1 is 
not limited to this compound. It only exemplifies the potential of the system and pro-
vides an alternative to produce biochemicals which can be troublesome to produce in 
conventional fermentations.  
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7.2	  	  	  	  	  Alternative	  feedstock	  and	  future	  production	  scenarios	  
In order to produce cost-competitive biochemicals, it is necessary to reduce the pro-
duction cost as much as possible. In the quest for reducing expenses we have investi-
gated the use of glycerol as an alternative substrate in Paper 2 (cf. chapter 2). Since 
glycerol is a poor substrate of P. putida an adaptive laboratory evolution experiment 
was made in order to improve growth rate. Furthermore, the usability of glycerol for 
supporting biofilm growth was investigated as most studies of P. putida are made us-
ing citrate as the carbon source. 
Lastly, some future applications and thoughts on production setups have been pre-
sented in Paper 3. The employment of various species into consortia for producing 
biochemicals is a field gaining increasing attention. The increasing knowledge of new 
species allows alternative production setup in which multiple organisms can be em-
ployed to utilise and produce compounds that are not achievable by using single or-
ganisms. In Paper 3 we present thoughts on how some of the recent studies exhibit 
evidence of how to construct synthetic communities. In this way artificial systems can 
be created composing of different consortia for bioconversion of successive steps of 
both substrates and intermediates for complex product formation. This could be used 
to develop a building block system in which different organisms can be combined 
based on the available substrate and product to be synthesised. In this way, it may not 
be necessary to transfer complex pathways between organisms. This is of particular 
interest when new organisms are found and their genomic potential revealed by ge-
nome sequencing. However, this is a future scenario.  
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Chapter	  8	  
Conclusions	  and	  perspectives	  
The results from this PhD study show that it is possible to use surface-associated bio-
film as a production platform for producing rhamnolipids. The challenges there may 
be in producing biochemicals that could potentially disrupt biofilm formation were 
not evident in this study. On the contrary, rhamnolipid production was in fact seen to 
stimulate biofilm production by facilitating cell motility. Hence, it offers an alterna-
tive to conventional setups and avoids some of their limitations. 
The engineered strains for producing rhamnolipids in this study have not been sub-
jected to any modifications for optimising the production. This could be achieved by 
removing the polyhydroxyalkanoate formation, as it is a competing pathway for the 
precursor β-hydroxyacyl-ACP used by the RhlA enzyme. By deleting the phaC1 
gene, approximately seven times more rhamnolipids could be produced (Wittgens et 
al., 2011). Another possibility for increasing rhamnolipid production could be by en-
hancing biofilm biomass. Mutating the lapG gene will result in an increased biofilm 
formation as the dispersal is hampered (Gjermansen et al., 2010, Yousef-Coronado et 
al., 2011). By having more cells encapsulated in the biofilm, more rhamnolipids 
could be synthesised. These aspects need to be addressed in order to increase rhamno-
lipid production in the biofilm.  
Furthermore, a scale up of the rhamnolipid production is necessary in order to inves-
tigate the real life applicability. The employed setup in this study is difficult to scale 
as it was intended as a proof of concept. The use of P. putida in large-scale biofilm 
reactors was however attempted during this PhD study. This was done in both an an-
nular biofilm reactor (BioSurface Technologies Corporation, Bozeman, USA) and by 
employing the BioBooster reactor (Grundfos, Denmark) (Lou et al., 2014). Particular-
ly the BioBooster reactor offered some interesting features, such as the capacity to 
maintain a uniform biofilm thickness by growing them on closely packed dishes. Un-
fortunately, we encountered some challenges in establishing biofilm on the plastic 
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surfaces used in both the annular biofilm reactor and the BioBooster. P. putida was 
not able to form biofilm on these surfaces. It may be possible to evade this limitation 
by employing high biofilm producing strains, for instance a lapG mutant of P. putida. 
However, this was not possible at that moment due to the classification of the pilot 
plant. In future studies, it will be relevant to investigate this setup for a large-scale 
production. Alternatively, some of the other available biofilm reactors could be con-
sidered, such as the trickle-bed biofilm reactor. The upscaling of the rhamnolipid 
production from our proof of concept study is critical for evaluating the applicability 
in a viable industrial production. 
A combination of using glycerol for producing rhamnolipids would be a natural con-
tinuation of the projects (Paper 1 and 2), as we showed glycerol could support biofilm 
growth. We have evolved strains with an increased growth rate and identified the mu-
tations giving rise to this enhancement. Further studies are, however, necessary in or-
der to be able to unravel the precise molecular mechanisms of these mutations. Based 
on the gained knowledge of glycerol metabolism from the evolved strains, new 
strains could be engineered which have an enhanced utilisation of glycerol and are 
able to produce rhamnolipids. In this process the aforementioned considerations for 
improving rhamnolipid synthesis should be included. Thus, an optimised rhamnolipid 
producing strain can be engineered using glycerol as the substrate. 
Other alternative feedstocks may also be considered, for instance lignocellulosic bio-
mass. The challenges of using such feedstocks are the presence of microbial inhibi-
tors, such as furfural (Behera et al., 2014). We did some preliminary studies elucidat-
ing the tolerance of P. putida to furfural and its effect on biofilm formation. These 
results indicated high tolerance of P. putida toward furfural both as planktonic cells 
and in biofilm. Hence, this could be a relevant alternative to pursue. 
One of the major obstacles in using biofilm as the production platform is the difficul-
ty of controlling the system. For biofilm to be an alternative for conventional fermen-
tation setups more knowledge should be gained in understanding and ideally control-
ling development of biofilm. The inherent heterogeneity of biofilm combined with 
the lowered metabolic activity makes production of biochemicals troublesome in 
terms of fluctuations as well as low production in case it is growth dependent. How-
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ever, biofilm offers many features that are invaluable in a production setup, such as 
high resistance and robustness. Hence, once the obstacles of heterogeneity have been 
overcome, biofilm will be a favourable alternative in producing biochemicals that are 
difficult in conventional bioreactors, as exemplified with rhamnolipids, and for pro-
ducing toxic compounds.  
The work presented in this PhD study was based on a single specie organism. The use 
of multi species communities as a production platform is another aspect which should 
be considered in future studies. Multi species consortia are the most prevalent form of 
life in nature and are of utmost interest for being employed in biotechnological appli-
cations. By employing multiple species, the community could exhibit features which 
are otherwise impossible to achieve. The use of multiple species is however challeng-
ing, as it is very complicated to handle and control multiple organisms simultaneous-
ly. Recent studies have however, highlighted the possible application and construc-
tion of artificial interdependence of organisms making such communities possible 
(Zhou et al., 2015, Minty et al., 2013). Similar studies could be made for combining a 
rhamnolipid producing strain with a strain converting xylose into other substrates. 
Xylose degradation can be engineered in E. coli (Zhang et al., 2015). By combining 
these two organisms, the E. coli strain can provide the substrate for P. putida, and the 
P. putida can produce the rhamnolipids. Since P. putida grow very poorly on xylose 
(Meijnen et al., 2008) and the E. coli growth is hampered by rhamnolipids at high 
concentrations (Wittgens et al., 2011), a mutual interdependence will exist between 
the organisms preventing them from outcompeting each other. The mutual ratio be-
tween these organisms will in this case be pivotal. An alternative option could be a 
community based on the fungus Trichoderma reesei and P. putida. In this consortium 
the fungus can degrade lignocellulose into monomers (Minty et al., 2013) which sub-
sequently can be used by P. putida. These are some examples of how this study can 
be extended to use microbial consortia for producing rhamnolipids by alternative sub-
strates. As a result, this field of research assure to be very promising and has the po-
tential to expand the possibilities within biotechnology considerably. 
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Abstract	  19 
Background: Although a transition toward a sustainable production of chemicals is 20 
needed, some biochemicals like biosurfactants are troublesome to produce by conven-21 
tional bioreactor setups. Alternative production platforms such as surface-attached 22 
biofilm populations could potentially overcome these problems. Rhamnolipids are a 23 
group of biosurfactants highly relevant for industrial applications. Unfortunately, they 24 
are mainly produced by the opportunistic pathogen Pseudomonas aeruginosa using 25 
hydrophobic substrates such as plant oils. As the biosynthesis is tightly regulated in P. 26 
aeruginosa a heterologous production of rhamnolipids in a safe organism can relive 27 
the production from many of these limitations and alternative substrates could be 28 
used.  29 
Results: In the present study a heterologous production of biosurfactants was investi-30 
gated using rhamnolipids as the model compound in biofilm encased Pseudomonas 31 
putida KT2440. The rhlAB operon from P. aeruginosa was introduced into P. putida 32 
to produce mono-rhamnolipids. Designing and employing a synthetic promoter li-33 
brary relieved the regulation of rhamnolipid synthesis and provided varying expres-34 
sion levels of the rhlAB operon resulting in different levels of rhamnolipid production. 35 
The biosynthesis of rhamnolipids decreased growth rate and stimulated biofilm for-36 
mation by enhancing cell motility. Continuous rhamnolipid production in a biofilm 37 
was achieved using flow cell technology. Quantitative and structural investigations of 38 
the produced rhamnolipids were made by ultra performance liquid chromatography 39 
(UHPLC) combined with high resolution mass spectrometry (HRMS) and tandem 40 
HRMS. The predominant rhamnolipid congener produced by the heterologous P. 41 
putida biofilm was mono-rhamnolipid with two C10 fatty acids.  42 
  
3 
Conclusion: This study shows a successful application of synthetic promoter library 43 
in P. putida KT2440 and a heterologous biosynthesis of rhamnolipids in biofilm en-44 
cased cells without hampering biofilm capabilities. These findings expands the possi-45 
bilities of cultivation setups and paves the way for employing biofilm flow systems as 46 
production platforms for biochemicals which, as a consequence of physiochemical 47 
properties are troublesome to produce in conventional fermenter setups, or for pro-48 
duction of compounds which are inhibitory or toxic to the production organisms. 49 
 50 
Introduction	  51 
Rhamnolipids is a group of biosurfactants with great industrial potential. Their low 52 
toxicity and biodegradability combined with their potent surface tension reducing and 53 
emulsifying activity has made them one of the most studied biosurfactants. Their pos-54 
sible applications range from industry, agriculture and bioremediation to personal care 55 
and medicine (Muller et al., 2012, Henkel et al., 2012). Rhamnolipids were first de-56 
scribed by (Jarvis and Johnson, 1949) and are produced by various organisms but 57 
mainly known from the opportunistic pathogen Pseudomonas aeruginosa in which 58 
most studies have been made. 59 
The rhamnolipids encompass a diverse group of compounds composed of one or two 60 
rhamnose molecules linked to one or two β-hydroxy fatty acids by β-glycosidic 61 
bonds. The rhamnose and fatty acid composition depend on strain and growth condi-62 
tions (Deziel et al., 1999, Muller et al., 2011). The most abundant rhamnolipid conge-63 
ner produced by P. aeruginosa is the di-rhamnolipid L-rhamnosyl-L-rhamnosyl-3-64 
hydroxydecanoyl-3-hydroxydecanoate (Rha-Rha-C10-C10) (Deziel et al., 1999).  65 
  
4 
The rhamnose moiety in rhamnolipids is synthesised from glucose (Rahim et al., 66 
2000, Aguirre-Ramirez et al., 2012) and the fatty acid is provided from de novo syn-67 
thesis (Zhu and Rock, 2008). Three enzymes mediate the synthesis of rhamnolipids in 68 
P. aeruginosa. The first step is the synthesis of 3-(3-hydroxyalkanoyloxy)alkanoate 69 
(HAA) mediated by RhlA (Deziel et al., 2003, Zhu and Rock, 2008). HAA is the li-70 
pidic precursor that together with dTDP-L-rhamnose is the substrate of RhlB for syn-71 
thesising mono-rhamnolipids (Rahim et al., 2001). The rhamnosyltransferase II (rhlC) 72 
is responsible for addition of another rhamnose moiety to make di-rhamnolipid 73 
(Rahim et al., 2001). The rhlA and rhlB genes constitute an operon (Pearson et al., 74 
1997, Ochsner et al., 1994) while rhlC is placed in another part of the genome (Rahim 75 
et al., 2001). Expression of the rhlAB operon in P. aeruginosa is highly regulated at 76 
multiple levels and subjected to both quorum sensing control as well as regulation by 77 
environmental factors such as phosphate, nitrate, ammonium and iron availability 78 
(Ochsner and Reiser, 1995, Pearson et al., 1997, Mulligan et al., 1989, Guerra-Santos 79 
et al., 1986, Mulligan and Gibbs, 1989, Deziel et al., 2003).  80 
The complex regulation of rhamnolipid synthesis makes it difficult to control biopro-81 
duction. Furthermore, P. aeruginosa is an opportunistic pathogen. To overcome these 82 
limitations various studies have been made in order to produce rhamnolipids in a het-83 
erologous host such as Escherichia coli, Pseudomonas fluorescens, Pseudomonas 84 
oleovorans and Pseudomonas putida (Zhu and Rock, 2008, Ochsner et al., 1995, 85 
Wittgens et al., 2011) by introducing the rhlAB operon. The ability of the host to tol-86 
erate rhamnolipid production can be a challenge as these molecules hamper growth at 87 
high concentrations (Wittgens et al., 2011). However, by using a species from the 88 
same genus a high inherent tolerance can be achieved as shown for P. putida 89 
(Wittgens et al., 2011, Ochsner et al., 1995). 90 
  
5 
The heterologous rhamnolipid production in P. putida KT2440 has so far been exam-91 
ined in conventional bioreactor systems with planktonic cells (Wittgens et al., 2011, 92 
Ochsner et al., 1995). This type of growth is associated with difficulties owing to 93 
foam formation caused by aeration of the culture (Muller et al., 2010, Reiling et al., 94 
1986, Urum and Pekdemir, 2004). We hypothesize that cultivation of cells in a sur-95 
face attached biofilm can reduce this problem.  In contrast to planktonic growth, bio-96 
films represent a sessile mode of growth, and cells growing in a biofilm have a low-97 
ered growth activity compared to their planktonic counterparts (Sternberg et al., 98 
1999). In rhamnolipid production this phenotype is desirable as production is growth 99 
independent and growth should be minimised in order to achieve high rhamnolipid 100 
yields (Muller et al., 2010, Wittgens et al., 2011).  101 
In the present study we use P. putida KT2440 biofilm as a production platform for 102 
heterologous production of rhamnolipids by constructing a synthetic promoter library 103 
(SPL). We show that producing rhamnolipids in a biofilm eliminates the formation of 104 
foam, which in other production setups result in significant challenges. A synthetic 105 
promoter library was designed and constructed to obtain various expression levels of 106 
rhamnolipid synthesis and to evaluate the effect of biosurfactant production on cells 107 
and on biofilm capabilities. A method for characterisation and quantification of the 108 
produced rhamnolipids was developed based on ultra-high performance liquid chro-109 
matography (UHPLC) combined with high resolution (HRMS) and tandem mass 110 
spectrometry (MS/HRMS). 111 
 112 
Results	  113 
 114 
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Using	  a	  synthetic	  promoter	  library	  to	  modify	  expression	  of	  rhlAB	  in	  P.	  putida	  	  115 
A previous study reported that the rhlI and rhlR need to be present in case the native 116 
rhlAB promoter from P. aeruginosa should be employed in a heterologous host 117 
(Ochsner and Reiser, 1995). Thus, for achieving high expression levels and to evalu-118 
ate the influence of rhamnolipid production on cells and biofilm formation, strains 119 
capable of producing rhamnolipids at different levels were engineered by constructing 120 
a synthetic promoter library (SPL) (Solem and Jensen, 2002) to drive expression of 121 
the rhlAB biosynthesis genes.  122 
The synthetic promoter library was constructed based on 16S rRNA promoter se-123 
quences from P. putida KT2440 and P. aeruginosa PAO1 in order to achieve strong 124 
constitutive promoters (Rud et al., 2006). The SPL was designed by preserving the 125 
consensus sequences and degenerating the surrounding bases to modulate promoter 126 
strength as previously described (Jensen and Hammer, 1998, Solem and Jensen, 127 
2002). The SPL was placed in front of the rhlAB operon to achieve varying expres-128 
sion levels of the rhamnolipid biosynthesis genes (Figure 1A). A gfp reporter was 129 
placed downstream of the rhlAB operon for determining the promoter strength. The 130 
promoter activities were determined at the single cell level by monitoring the gfp ex-131 
pression. This enabled indirect monitoring of the rhamnolipid biosynthesis.  132 
The wild type strain and a strain harbouring the gfp reporter vector without a promot-133 
er showed no significant difference in fluorescence intensity (Figure 1B). The pro-134 
moter activity of the rhlAB operon without SPL and the native promoter from PAO1 135 
showed a small but significant increase in activity compared to the reference vector, 136 
indicating an inherent but low promoter activity ascribed to the rhlAB operon. How-137 
ever, in these two cases rhamnolipid production could not be detected (data not 138 
shown). The constructed SPL resulted in a diverse set of synthetic promoters with 139 
  
7 
varying strength (Figure 1C). The majority of the synthetic promoters supported high-140 
er gfp expression levels than the control strains. An investigation of the SPL activity 141 
revealed a distribution of expression levels with most promoters between 10 and 50 142 
a.u.  143 
 144 
Gfp	  expression	  correlates	  with	  rhamnolipid	  production	  145 
The synthetic promoter strength determined by Gfp fluorescence should reflect a cor-146 
responding expression of the rhlAB operon (Figure 1A). To evaluate the correlation 147 
between fluorescence intensity and rhlAB expression we analysed rhamnolipid pro-148 
duction in a selection of strains with synthetic promoters of different strengths. To 149 
this end, we developed a method based on ultra performance liquid chromatography 150 
(UHPLC) combined with high resolution mass spectrometry (HRMS) and tandem 151 
HRMS for simultaneous quantitative and qualitative analysis of the produced rhamno-152 
lipids (Supporting information Figure S1 and Table S1). The rhamnolipid congeners 153 
were identified and quantified based on their elemental composition (Figure 2) and 154 
were verified by positive and negative electrospray ionisation in UHPLC-HRMS. 155 
Although a mixture of rhamnolipids could be produced by P. putida, the predominant 156 
congener was Rha-C10-C10 followed by Rha-C10-C12, Rha-C10-C12:1 and Rha-C8-C10 157 
(Supporting information Figure S1). The structural composition was elucidated by 158 
MS/HRMS fragmentation pattern (Supporting information Table S1). These results 159 
are in accordance with previous results (Deziel et al., 1999, Rudden et al., 2015). The 160 
elution pattern supported the determined structural composition.  161 
Analysis of rhamnolipid production in a selection of 6 strains with different synthetic 162 
promoter strengths revealed a clear linear correlation between Gfp activity and Rha-163 
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C10-C10 concentration (Figure 3). Hence, Gfp fluorescence can be used as an indirect 164 
measure of rhamnolipid production.  165 
 166 
The	  cost	  of	  producing	  rhamnolipids	  167 
The wide range of synthetic promoter strengths made it possible to investigate the 168 
metabolic load associated with rhamnolipid production. We found that increased 169 
rhamnolipid production is correlated to a reduction in growth rate (Figure 4). A 10 170 
fold increase in rhamnolipid production result in a 14% lower growth rate. 171 
 172 
Heterologous	   expression	   of	   rhamnolipids	   in	  P.	   putida	   result	   in	   enhanced	   biofilm	  173 
production	  174 
Rhamnolipids are biosurfactants that may potentially interfere with P. putida biofilm 175 
formation (Diaz De Rienzo et al., 2016). To investigate the effect of rhamnolipid pro-176 
duction on biofilm capabilities of the engineered strains, we used microtiter plate 177 
based assays to measure biofilm formation as a function of time. In these assays, the 178 
biofilm development of all strains followed a similar biofilm developmental progress 179 
with dispersal of the biofilm upon reaching their maximal quantity (Figure 5) as pre-180 
viously described for P. putida biofilm formation (Gjermansen et al., 2010). Surpris-181 
ingly, the rhamnolipid producing strains had an enhanced biofilm production and 182 
reached a higher biomass compared to the reference strain. The decrease in planktonic 183 
growth rate (Figure 4) was reflected in a slower biofilm development of the high 184 
rhamnolipid producer although a higher biomass than the reference strain was eventu-185 
ally reached (Figure 5). The medium rhamnolipid producer and the reference strain 186 
follow the same biofilm development until the dispersal of the reference strain. Here-187 
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after, the rhamnolipid producing strain continues to grow and reach 60% more bio-188 
mass than the reference strain. The amount of produced rhamnolipids does have an 189 
impact on the biofilm dispersal. Although both of the rhamnolipid producing strains 190 
reached a higher biofilm biomass, the biofilm dispersal initiates earlier in the high 191 
rhamnolipid producer than the medium rhamnolipid producer. Hence, the amount of 192 
present rhamnolipids does have an impact on dispersal, however, compared to the ref-193 
erence strain rhamnolipid producers reach higher biofilm biomass.  194 
 195 
Heterologous	  expression	  of	  rhamnolipids	  in	  P.	  putida	  increase	  swarming	  motility	  196 
Rhamnolipids have been shown to have an effect on both swarming motility and bio-197 
film formation in P. aeruginosa (Pamp and Tolker-Nielsen, 2007), and similar motili-198 
ty-related effects could explain the observation of altered biofilm formation in our 199 
engineered P. putida strains. Indeed, we observed that heterologous expression of 200 
rhamnolipids in P. putida results in an increase of swarming motility and expansion 201 
of colonies on solid surfaces (Figure 6). In order to verify that the increased expansion 202 
was a result of rhamnolipids the assay was repeated in the presence of the surfactant 203 
Tween 20. This resulted in increased colony size of the reference strain. Although the 204 
colony did not become as large as the rhamnolipid producing strain it increased by 205 
more than 2 fold. The presence of Tween 20 did not have a great influence on the 206 
rhamnolipid producing strain. This could be a consequence of an abundant quantity of 207 
rhamnolipids compared to Tween 20.  208 
 209 
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Continuous	  production	  of	  rhamnolipids	  in	  biofilm	  encased	  P.	  putida	  	  210 
A continuous production of rhamnolipids using biofilm as the production platform 211 
was evaluated using flow cell technology (Tolker-Nielsen and Sternberg, 2011, 212 
Gjermansen et al., 2010). The biofilm was grown on a glass substratum and growth 213 
was followed in situ using confocal laser scanning microscopy. A high and a medium 214 
rhamnolipid producer were grown and the rhamnolipid content quantified and com-215 
pared to the reference strain. Representative pictures of the high rhamnolipid producer 216 
(VW224) and the reference strain (VW230) are shown in Figure 7. No apparent visual 217 
difference in the biofilm morphology was observed. However, the VW224 biofilm 218 
appeared to contain more biomass. For quantitative comparison the biomass was 219 
quantified based on the obtained pictures using COMSTAT2 (Heydorn et al., 2000, 220 
Vorregaard, 2008). Figure 8A, B and C show the quantified biomass of the biofilm 221 
from flow chambers. The fluctuations observed in the quantification demonstrate the 222 
heterogeneity and complexity of biofilm. The biofilm biomass is difficult to quantify, 223 
specially for P. putida biofilm (Heydorn et al., 2000). Even though fluctuation occur a 224 
quantitative measure of the biomass enables comparison across the strains, particular-225 
ly when combined with crystal violet assays. The biofilm stimulating effect observed 226 
in the microtiter assay (Figure 5) is also evident in flow chambers (Figure 8D). Alt-227 
hough the biomass fluctuates the rhamnolipid production showed to be consistent and 228 
reaches a stabile level after which the production is constant for both the medium and 229 
the high rhamnolipid producer (Figure 9). The rapid achievement of maximal produc-230 
tion titter reflects a fast and reproducible establishment of a biofilm capable of pro-231 
ducing rhamnolipids. Both the biofilm and the rhamnolipid production were stably 232 
maintained during the cultivation period.  233 
 234 
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Discussion	  	  235 
The quest for replacing petrochemicals with biochemicals gives challenges in finding 236 
the optimal organism and cultivation conditions. In this study we have explored the 237 
potential of biofilms as alternative production platform for biosynthesis of chemicals 238 
which are inherently troublesome to produce in conventional bioreactor setups.  239 
 240 
Heterologous	  biosynthesis	  and	  detection	  of	  rhamnolipids	  in	  P.	  putida	  241 
Although the fast and reliable method of using synthetic promoter libraries has been 242 
employed for several species (Solem and Jensen, 2002, Rud et al., 2006, Rytter et al., 243 
2014, Sohoni et al., 2014), this is the first time this technique has been employed for 244 
Pseudomonas ssp. The use of SPL made it possible to investigate the impact of heter-245 
ologous rhamnolipid production in P. putida regarding growth rate and biofilm capa-246 
bilities. We selected a constitutive rather than an inducible promoter design, as the 247 
even distribution of inducers into the biofilm could be hindered by biofilm specific 248 
factors such as the extracellular matrix. Importantly, we showed that rhamnolipids 249 
promotes biofilm formation, constitutive production will not limit biofilm establish-250 
ment (Figure 5 and Figure 8).  251 
Rhamnolipid production has been investigated in both P. putida and P. aeruginosa 252 
(Ochsner et al., 1995, Wittgens et al., 2011). Many of these studies have been made 253 
by indirect quantification and by measuring the total pool of rhamnolipids, although it 254 
is well known that different rhamnolipid congeners are made resulting in different 255 
physiochemical properties (Deziel et al., 1999). We aimed to investigate the applica-256 
bility of biofilm as a production platform for rhamnolipids, it was crucial to develop a 257 
method by which the different congeners could be determined in case alterations in 258 
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composition occurred as a consequence of perturbations in the intracellular metabo-259 
lites. Furthermore, as production of rhamnolipids in a biofilm will result in low titers, 260 
a sensitive method for detection of small changes in rhamnolipid concentration was 261 
necessary. 262 
With our method, we observed the fatty acid composition of the rhamnolipids to vary 263 
between C8 to C12 with C10 being the most abundant (Deziel et al., 1999, Rudden et 264 
al., 2015). This is similar to the rhamnolipids produced by P. aeruginosa (Deziel et 265 
al., 1999, Rudden et al., 2015), and is expected due to the substrate specificity of rhlA 266 
from P. aeruginosa to C10 fatty acids (Zhu and Rock, 2008). The lower limit of detec-267 
tion of our method was 0.09 mg/L (data not shown) which is comparable to the meth-268 
od recently published by (Rudden et al., 2015).  269 
 270 
Biofilm	  as	  a	  production	  platform	  	  271 
Excessive foaming during rhamnolipid production in conventional bioreactors system 272 
remains a challenging problem in relation to maintaining sterility (Muller et al., 2010, 273 
Reiling et al., 1986, Urum and Pekdemir, 2004). In addition to being a problem in 274 
maintaining sterility, foam formation can also result in disturbances of the culture 275 
broth and thereby result in decreased rhamnolipid production (Reiling et al., 1986). In 276 
this study we eliminated foam production by employing biofilm encapsulated cells in 277 
a flow system as production platform.  278 
The biofilm mode of growth represent another set of challenges not present in other 279 
bioreactor systems. For example, since rhamnolipids are biosurfactants they could 280 
have a severe impact on the biofilm formation process by dissolving the encapsulated 281 
cells. Rhamnolipids could potentially be involved in removing extracellular polymeric 282 
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substances thereby destabilising the biofilm and consequently disrupting it (Diaz De 283 
Rienzo et al., 2016). However, we found that rhamnolipids stimulated P. putida bio-284 
film formation through enhanced cell motility as previously shown for P. aeruginosa 285 
(Pamp and Tolker-Nielsen, 2007). However, the difference in biofilm morphology 286 
was not as pronounced in our P. putida biofilms as observed in P. aeruginosa (Pamp 287 
and Tolker-Nielsen, 2007). We also observed that the amount of rhamnolipds has an 288 
effect on biofilm dispersal. The more rhamnolipids are produced the earlier the bio-289 
film dispersal occur. The presence of rhamnolipids does however result in more bio-290 
film biomass compared to the reference strain in all cases (Figure 5). Hence, there is 291 
an optimum for biofilm biomass and rhamnolipid content after which the biomass 292 
starts to decline.  293 
Instability of biofilm cells has been reported in other studies as cell morphology did 294 
change during the cultivation time (Gross et al., 2010). We verified the expression of 295 
the rhlAB genes in the biofilm by employing the plasmid encoded gfp reporter for 296 
visualisation of the in situ biofilm. In our case no changes were observed in relation to 297 
plasmid loss (data not shown), change in morphology or decreased rhamnolipid pro-298 
duction.  299 
In the present study we have focused on using biofilm as a platform for producing 300 
rhamnolipids and the associated challenges. Hence, no optimisations of the cells were 301 
made for increasing the production as well as for increased biofilm formation. A can-302 
didate for increasing production could be to reduce diversion of precursors from the 303 
biosynthesis of rhamnolipids. Wittgens et al. (2011) eliminated the synthesis of poly-304 
hydroxyalkanoate as this competes for the rhamnolipid precursor HAA. This modifi-305 
cation resulted in an increased yield. This could be the first step in order to achieve 306 
higher production titters. Wittgens et al. (2011) also showed rhamnolipid synthesis to 307 
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be growth independent and growth should be minimised for increasing the yield. We 308 
took advantage of this knowledge in using biofilm as the production platform for het-309 
erologous synthesis of rhamnolipids. The lowered growth activity of biofilm encased 310 
cells (Sternberg et al., 1999) should reflect an increased yield without hampering the 311 
biosynthesis. Another possibility is to increase productivity by increasing the precur-312 
sors for rhamnolipid synthesis. This can be mediated by perturbing the intracellular 313 
energy levels and increase the ATP demand. Introducing the F1 part of the membrane 314 
bound F0F1 H+-ATP synthase increased the glycolytic flux in E. coli (Koebmann et 315 
al., 2002). This may stimulate the intracellular processes and thereby increase the syn-316 
thesis of rhamnolipids by stimulating the synthesis of precursors.  317 
Other areas for further improvements of our production platform include prevention 318 
of biofilm dispersal by genetic engineering as previously described (Gjermansen et 319 
al., 2010), and to integrate the production genes into the chromosome of the bacteria 320 
to eliminate possible loss of plasmids during production (although the employed 321 
plasmid can be stably maintained in P. fluorescens without selection (Heeb et al., 322 
2000)). 323 
 324 
Conclusion	  	  325 
In this study we were able to successfully utilise biofilm as a production platform. By 326 
employing SPL we characterised the effect of producing rhamnolipids in relation to 327 
growth and on biofilm capabilities of the non-pathogenic bacterium P. putida. The in 328 
situ investigation of the biofilm formation enabled invaluable exploration of the effect 329 
of producing rhamnolipids. This study adds on to the increasing knowledge of P. 330 
putida and the wide applicability of this organism in industrial settings. The continu-331 
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ous production of rhamnolipids exemplified in this study show that this mode of 332 
growth can support production of troublesome biochemicals. A continuous production 333 
of biochemicals eliminate product inhibition and the inherent resistance of biofilm 334 
make it a competent candidate for producing biochemicals which are toxic as well as 335 
for using alternative feedstocks without being necessitated to make a detoxification.  336 
  337 
Materials	  and	  methods	  338 
Strains	  and	  growth	  conditions	  339 
E. coli DH5α strain was used for standard DNA manipulations. Pseudomonas aeru-340 
ginosa PAO1 and Pseudomonas putida KT2440 were used for synthetic promoter li-341 
brary construction. The employed strains are listed in Table 1. The strains were prop-342 
agated in modified Lysogeny broth (LB) medium containing 4g of NaCl/liter instead 343 
of 10 g NaCl/liter and with peptone instead of tryptone (Bertani, 1951). Biofilm ex-344 
periment in flow chambers were made in modified FAB medium (Heydorn et al., 345 
2000) supplemented with 1 mM sodium citrate. Biofilm inoculum was supplemented 346 
with 10 mM sodium citrate. Tetracycline concentration of 8 µg/mL and 20 µg/mL 347 
was used for E. coli and P. putida, respectively. E. coli and P. aeruginosa were incu-348 
bated at 37°C and P. putida at 30°C.  349 
 350 
Construction	  of	  synthetic	  promoter	  library	  351 
The reporter plasmid pVW10 was constructed by PCR amplification of gfpmut3* us-352 
ing Phusion polymerase and the primers Gfp_fwd and Gfp_rev, followed by double 353 
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digestion of the fragment and vector pME6031 with EcoRI and PstI. These were li-354 
gated together by T4 DNA ligase.  355 
Constitutive SPL of the rhlAB operon was constructed as described by (Solem and 356 
Jensen, 2002). The SPL was based on putative rRNA promoters extracted from the 357 
genome sequence of P. putida KT2440 (accession number: NC_002947) and P. aeru-358 
ginosa PAO1 (accession number: NC_002516). Promoters of varying strength were 359 
obtained by randomisation of the nucleotides surrounding -10 and -35 consensus se-360 
quences (primers: SPL_rhlAB and rhlAB_rev). The native promoter of the rhlAB op-361 
eron in P. aeruginosa PAO1 and a promoterless rhlAB operon were made as reference 362 
to the constructed SPL and for validation of promoter activity (primers: Na-363 
tive_rhlAB, SPL_con_rhlAB and rhlAB_rev).  364 
Genomic DNA from P. aeruginosa PAO1 was extracted using Wizard Genomic DNA 365 
Purification Kit (Promega). The rhlAB operon was PCR amplified from genomic P. 366 
aeruginosa PAO1 using Phusion polymerase. The employed primers are listed in Ta-367 
ble 1. Following double digestion of the fragments containing rhlAB operon and vec-368 
tor pVW10 with BglII and EcoRI these were ligated together with T4 DNA ligase. All 369 
enzymes for DNA manipulations were bought from ThermoFisher Scientific and used 370 
as recommended. Primers were purchased from Integrated DNA Technologies. The 371 
SPL rhlAB primer was purchased as ultramer.  372 
The SPL was introduced into P. putida by electroporation (Choi et al., 2006) to avoid 373 
biases in promoter strength by using E. coli as an intermediate strain. The SPL was 374 
constructed in three independent rounds. Pseudomonas putida KT2440 containing 375 
SPL were randomly picked followed by manual inspection for highly active promot-376 
ers missed in the random selection.  377 
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For biofilm formation in flow chambers the reference strain containing P. putida 378 
pVW10 was fluorescently tagged at an intergenic neutral chromosomal locus with gfp 379 
in mini-Tn7 constructs as described by (Koch et al., 2001). The rhamnolipid produc-380 
ing mutants were visualised by the plasmid encoded gfp reporter gene.  381 
 382 
GFP	  analysis	  383 
The promoter strength was determined by quantification of gfp expression at single-384 
cell level by flow cytometry. The P. putida strains containing the promoter library 385 
were grown in LB medium supplemented with tetracycline in 96-well microtiter 386 
plates. Overnight cultures of approximately 16h were diluted 50 fold and incubated 387 
for an additional 3h at 30°C with shaking at 600 rpm to ensure exponentially growth. 388 
The cultures were diluted 5 times in 0.9% NaCl before measuring gfp expression on a 389 
FACSCalibur (Becton Dickinson) flow cytometer. The data was analysed in FlowJo. 390 
 391 
Rhamnolipid	  extraction	  and	  analysis	  392 
A mono-rhamnolipid standard was used for calibration and validation purposes (Sig-393 
ma-Aldrich). Cells were removed by filtration (0.22µM) and the supernatant, 1 mL, 394 
was mixed with 2 times the volume of 70% acetonitrile. A two-phase separation was 395 
achieved by addition of a mixture of sodium sulphate and sodium chloride powder ≈ 396 
100 mg followed by centrifugation at 4500 × g for 5 min (QuEChER extraction) 397 
(Anastassiades et al., 2003). Chloramphenicol (50 mg/mL in ethanol) was added to a 398 
final concentration of 10 µg/mL as internal standard. The organic phase was trans-399 
ferred to HPLC vials and analysed on a reverse phase UHPLC-HRMS on a maXis 400 
HD quadrupole time of flight (qTOF) mass spectrometer (Bruker Daltonics, Bremen, 401 
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Germany) connected to an Ultimate 3000 UHPLC system (Dionex, Sunnyvale, CA, 402 
USA) equipped with a 10 cm Kinetex C18 column (Phenomenex Torrance, CA, USA) 403 
running a linear 10-100% gradient for 15 min at 40°C and a flow at 0.4 ml/min 404 
(Klitgaard et al., 2014). The qTOF was operated in ESI- negative mode, scanning m/z 405 
50-1300, with alternating fragmentation energy over the quadrupole of 0 and 25 eV, 406 
each for 0.25 s.  407 
 408 
UHPLC-­‐HRMS	  data	  analysis	  409 
Extracted ion chromatograms (± 2 mDa) of the [M-H]- ions were constructed from the 410 
0 eV volt data using Compass TargetAnalysis (version 1.3 Bruker Daltonics), which 411 
also verified the isotopic patterns (I-fit <50).  The 25 eV volt data were used to verify 412 
identity of the rhamnolipids, as fragment ions of rhamnose and one fatty acid moiety 413 
cold be identified by the loss of the fatty acid distant to the rhamnose molecule (Sup-414 
porting Information figure S1). The retention time (± 0.02 min) was compared to an 415 
authentic standard (Sigma-Aldrich). The rhamnolipid standard contained according to 416 
the manufacture 90% mono-rhamnolipid and 5% di-rhamnolipid, each of these con-417 
tained several congeners with different fatty acid chains. Each of the mono-418 
rhamnolipid congeners were integrated, [M-H]-, and their fractions determined in the 419 
purchased standard. The standard contained the following fractions of congeners:  420 
84.1% Rha-C10-C10, 9.7% Rha-C8-C10 to; 3.4% Rha-C10-C12:1, 2.5% Rha-C10-C10:1 and 421 
0.3% Rha-C10-C12, 422 
Calibration of rhamnolipids was made in acetonitrile-water (1:1 v/v) dilutions. The 423 
peak areas of rhamnolipids were normalised to that of chloramphenicol [M-H]- (10 424 
ug/ml). The standards were made in steps of 0.2 µg/mL from 0.5 µg/mL to 1.7 µg/mL 425 
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and from 1.7 µg/mL to 30 µg/mL in steps of 2 µg/mL. Limit of detection was deter-426 
mined as the lowest point where a peak with s/n of 15 could be detected. Limit of de-427 
tection was 0.09 µg/mL. R2 of 0.995 was obtained in the range 0.09 µg/mL to 12 428 
µg/mL of the standard.  429 
 430 
Swarming	  motility	  431 
Swarming motility was assayed in LB medium containing 20 µg/mL tetracycline and 432 
solidified with 0.5% agar. The plates were point inoculated at the surface and incubat-433 
ed for 24 h at 22°C.  434 
 435 
Crystal	  violet	  biofilm	  assay	  436 
Quantification of biofilm formation in static microtiter dishes was made by crystal 437 
violet staining as described by (O'Toole and Kolter, 1998). Briefly, over night cul-438 
tures were diluted to an OD600 of 0.010 and inoculated in 100 µL LB supplemented 439 
with 20 µg/mL tetracycline for the specified time. The wells were emptied and 440 
washed with 0.9% NaCl followed by 15 min of staining with 0.1% crystal violet 441 
(Sigma-Aldrich). The wells were washed twice in saline and adhered crystal violet 442 
was subsequently solubilised in 96% ethanol for 15 min before quantification by 443 
spectrometry at Abs595. Microtiter dished were made of polystyrene (TPP Techno 444 
Plastic Products AG).  445 
 446 
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Biofilm	  cultivation	  in	  flow	  chambers	  447 
Biofilms were cultivated in three-channel flow chambers with individual channel di-448 
mensions of 1×4×40 mm covered with glass coverslip (Knittel 24x50mm) serving as 449 
substratum for biofilm formation. The system was prepared and assembled as previ-450 
ously described by (Tolker-Nielsen and Sternberg, 2011). Overnight cultures were 451 
made in modified FAB medium supplemented with 10 mM sodium citrate. The over-452 
night cultures were diluted to an OD600 of 0.010 and aliquots of 500 µL were inocu-453 
lated into each channel of the flow chambers. Bacterial attachment was allowed for 1 454 
h with the chambers turned upside down without flow. The flow systems was incu-455 
bated at 22°C with a laminar flow rate of 3 mL/h obtained by a Watson Marlow 205S 456 
peristaltic pump. Modified FAB medium supplemented with 1 mM of sodium citrate 457 
was used for biofilm cultivation (Heydorn et al., 2000). Tetracycline was added to the 458 
growth medium for plasmid maintenance. Bacterial growth upstream of the flow 459 
channels were removed by cutting the affected part of the tubing under sterile condi-460 
tions and reattached the tubes to the flow channel.  461 
 462 
Microscopy	  and	  image	  processing	  463 
Biofilm was followed in situ using a Leica TCS SP5 confocal laser scanning micro-464 
scope equipped with detectors and filters set for monitoring Gfp fluorescence. Images 465 
were obtained with a 63x/1.20 water objective. Images of the biofilm were taken at 466 
the specified time points. Images were all acquired form random positions at a dis-467 
tance of 5-10 mm from the inlet of the flow channels. Biomass of the biofilm was de-468 
termined based on the acquired pictures by employing COMSTAT2 (Heydorn et al., 469 
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2000, Vorregaard, 2008). Simulated three-dimension images were generated using the 470 
Imaris software package (Bitplane AG).  471 
 472 
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Figures	  649 
 650 
 651 
Figure 1. Construction and utilization of a synthetic promoter library in P. putida. (A) 652 
Outline of the plasmid construction strategy. The genes gfp, rhlA and rhlB indicate the 653 
green fluorescence protein, rhamnosyltransferase chain A and rhamnosyltransferase 654 
chain B, respectively. SPL indicate synthetic promoter library. The X in pVW12-655 
SPLX represents any of the 120 synthetic promoters constructed in this study (see 656 
Materials and methods). (B) Gfp fluorescence measurement in a series of control 657 
strains without SPL. The control strains are wild type strain (P. putida) and strains 658 
containing an empty vector (pVW10), plasmid containing rhlAB operon (pVW13) 659 
with no promoter and the rhlAB operon with the native promoter from PAO1 660 
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(pVW14). The asterisks represent a significant difference (P<0.05). (C) The different 661 
promoter strength in the constructed SPL determined as Gfp intensities. The controls 662 
strains depicted in figure (C) are shown in grey. The columns represent mean value 663 
and the error bars indicate standard deviation. The Gfp intensities have been replicat-664 
ed 1 to 3 times. 665 
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 667 
 668 
 669 
Figure 2. Outline of the different rhamnolipid congeners. The grey part of the struc-670 
ture is the varying part of the molecule. The numbers indicate the length of the fatty 671 
acid side chain. The most predominant congener produced by the recombinant P. 672 
putida is Rha-C10-C10. The different rhamnolipid congeners were determined based on 673 
their elemental composition.  674 
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 676 
 677 
 678 
Figure 3. Correlation between gfp expression and Rha-C10-C10 concentration. The lin-679 
ear correlation between gfp and Rha-C10-C10 enable fluorescence to be used as an in-680 
direct measure of rhamnolipid biosynthesis. 681 
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 683 
 684 
 685 
Figure 4. Correlation between rhamnolipid production and growth rate. Biosynthesis 686 
of rhamnolipids has an impact on planktonic growth rate. The cells grow slower as 687 
they produce more rhamnolipids.  688 
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 690 
 691 
 692 
 Figure 5. Biofilm development in microtiter plate assays. The amount of biofilm was 693 
quantified for the reference strain (black), a medium rhamnolipid producer (red) and a 694 
high rhamnolipid producer (green) at the specified time points. Each data point repre-695 
sents the mean and the error bars indicate standard deviations of eight technical repli-696 
cates.  697 
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 701 
 702 
                - Tween 20        + Tween 20 
 
 
 
 
P. putida pVW10 
 
 
 
 
 
 
 
 
 
P. putida pVW12-SPL4 
Figure 6. Effect of rhamnolipid and the surfactant Tween 20 on swarming motility. 703 
The top row is the reference strain and the bottom row is a rhamnolipid producer. The 704 
right column has been added 0.0005% Tween 20 and the left column have not. The 705 
scale bars indicate the size of 1 cm on the pictured strain. The presence of Tween 20 706 
increased the swarming motility of both strains but in particular for the reference 707 
strain.  708 
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 710 
 711 
Figure 7. Biofilm development of a high rhamnolipid producing P. putida  (VW224) 712 
and the reference strain (VW230). Depicted are representative pictures of biofilm 713 
from the specified days. The scale bar indicates the size of 50 µm. 714 
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 716 
 717 
Figure 8. Biofilm biomass quantification. The biomass was quantified based on the 718 
obtained CSLM pictures. Panel A is the reference strain VW230, panel B is the medi-719 
um rhamnolipid producer VW98, and panel C is the high rhamnolipid producer 720 
VW224. In panel D the strains are combined and only the mean values are depicted 721 
for clarity. The symbols represent the mean biomass and the error bars the standard 722 
deviation based on two biological replicates each composed of 7-11 pictures.  723 
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 726 
Figure 9. Continuous rhamnolipid production in a biofilm system. The reference 727 
strain (VW230), a medium (☐VW98) and a high (ΔVW224) rhamnolipid producer 728 
were cultivated for seven days and the rhamnolipid production quantified. The sym-729 
bols represent mean concentration and the error bars the standard deviation of two 730 
biological replicates.  731 
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Tables	  733 
Table 1 – Strains, plasmids and primers used in this study. The restriction sites on the 734 
primers are indicated by underscore. N indicate a randomised base representing 25% 735 
of A, C, G or T.  736 
Strain, plasmid or 
primer 
Relevant characteristic or sequence Reference 
Strains   
 E. coli DH5α Host for plasmid maintenance  Laboratory strain 
 P. putida Wild type strain; used for heterologous expression of 
rhlAB operon 
(Bagdasarian et al., 
1981)  
 P. aeruginosa Wild type strain; used for amplification of rhlAB oper-
on 
(Holloway, 1955) 
Plasmids   
 pBK-miniTn7-gfp2  Gmr; PrnB P1gfpAGA 
Delivery vector for miniTn7-gfp2 
(Koch et al., 2001) 
 pRK600 Cmr; oriColE1 RK2-mob+ RK2-tra+  
Helper plasmid in mating 
(Kessler et al., 1992) 
 pUX-BF13 Apr; mob+ oriR6K  
Helper plasmid providing Tn7 transposition function in 
trans 
(Bao et al., 1991) 
 pJBA27 gfpmut3* (Andersen et al., 
1998) 
 pME6031 Tcr; derivate of pME6010; clonings vector maintained 
in Pseudomonas strains without selection pressure 
(Heeb et al., 2000) 
 pVW10 pME6031::gfpmut3* This study 
 pVW13 pVW10 with promoterless rhlAB This study 
 pVW14 pVW10 with rhlAB and its native promoter  This study 
 pVW12-SPL1 to 
pVW12-SPL120 
SPL in front of rhlAB This study 
Primers   
 Gfp Fwd 5’-AGATAGAATTCAGATTCAATTGTGAGCGG-3’ 
 Gfp rev 5’-AGATACTGCAGTATCAACAGGAGTCCAAGC-3’ 
 SPL rhlAB 5’-AGATAAGATCTACN10TTGACAN16TATAATN6CCCG-
ATCGGCTACGCGTGAACA-3’ 
 rhlAB rev 5’-AGATAGAATTCATCACAGCAGAATTGGCCC-3’ 
 SPL con rhlAB 5’-AGATAAGATCTATCGGCTACGCGTGAACA-3’ 
 Native rhlAB 5’-AGATAAGATCTACCCTGCCAAAAGCCTGA-3’ 
 737 
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 2 
Rhamnolipid	  identification	  17 
Identification of the rhamnolipid congeners was based on their elementary composi-18 
tion. For identification of any possible rhamnolipid congeners in a sample, a list con-19 
taining different combinations of rhamnose and fatty acids with varying chain length 20 
and saturation was used for screening the chromatograms (Table S 1). However, the 21 
engineered P. putida host only produced a few different congeners (Figure S 1A). The 22 
chromatograms are based on the obtained mass spectrum (Figure S 1B) which shows 23 
the determined m/z values.  24 
The abovementioned screening method suffers from the lack of ability to discriminate 25 
between isomers, e.g. between Rha-C12-C10 and Rha-C10-C12. For this reason pseudo 26 
MS/HRMS (MS-E) was made for structural identification of the different congeners. 27 
The fragmentation pattern of the rhamnolipid congeners revealed the fatty acid com-28 
position and was used for the identification (Table S 1 and Figure S 1C,D). An exam-29 
ple of fragmentation is shown for Rha-C10-C10 in Figure S 1D. The fragmentation 30 
point is indicated resulting in a m/z 333.1913 ion which is apparent in the 25 eV mass 31 
spectrum together with the lost fatty acid moiety of m/z 169.1239. In this way both the 32 
length of the fatty acid and their mutual position was elucidated. The obtained results 33 
correspond with previous results (Rudden et al., 2015, Deziel et al., 2000). 34 
 3 
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Figure	  47 
 48 
Figure S 1 – UHPLC-HRMS analysis of rhamnolipids. Picture A is the extracted ion 49 
chromatogram of the internal standards and the four most abundant rhamnolipid con-50 
geners from the engineered P. putida strain VW224. The first peak is chlorampheni-51 
col followed by the rhamnolipid congeners Rha-C8-C10, Rha-C10-C10, Rha-C10-C12:1 52 
and Rha-C12-C12. The full scan mass spectrum of the most predominant rhamnolipid 53 
congener Rha-C10-C10 is shown in figure B. The 25 eV mass spectrum of Rha-C10-C10 54 
is depicted in figure C. In figure C the [M-H]- ion and the fragmented ion can be seen 55 
from the pseudo MS/MS analysis. An example of the fragmentation pattern is shown 56 
in figure D for Rha-C10-C10. The breaking point and the resulting fragment masses are 57 
indicated in red. 58 
 59 
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Table	  61 
Table S 1 – The rhamnolipid congeners screened in the chromatograms. Pseudomo-62 
lecular ions and fragmentation ions used for structural identification of the different 63 
rhamnolipid congeners is shown. The MS/MS ions are the fragmented ions. The first 64 
ion is the rhamnose and one fatty acid residue and the next is the fatty acid ion. The 65 
ions marked with * could be identified in the MS/MS (25eV mass spectrum). The re-66 
maining ions could not be identified due to the absence of the congener or very low 67 
presence.  68 
Compound MS 
[M-H]- 
MS/MS 
[M-H]-  
Rha-C10-C10 503.3226 333.1925* - 169.1239* 
Rha-C10-C12 531.3539 333.1925* - 197.1549* 
Rha-C10-C12:1 529.3382 333.1925* - 195.1390* 
Rha-C8-C10 475.2913 305.1603* - 169.1239* 
Rha-C12-C12:1 557.3695 360.2148 – 197.1542 
Rha-C12-C12 559.3852 360.2148 – 199.1698 
Rha-C10-C10:1 501.3069 333.1925 – 167.1083 
Rha-C8-C8 447.2594 305.1603 – 143.1072 
Rha-C8-C8:1 445.2437 305.1603 – 141.0916 
Rha-C8-C10:1 473.2750 305.1603 – 169.1229 
 69 
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Abstract	  17 
A transition toward renewable resources is needed in order to obtain sustainable pro-18 
duction of chemicals. One such alternative feedstock is the waste material crude glyc-19 
erol generated from the biodiesel production. The utilisation of this abundant low cost 20 
feedstock is desirable in reducing the production costs. The exploitation is however 21 
often associated with hampered microbial growth owing to the residual impurities 22 
from the transesterification process generating biodiesel. The bacterium Pseudomonas 23 
putida has shown not to be severely affected by these impurities. Glycerol does how-24 
ever not provide substantial proliferation of Pseudomonas putida. We improved glyc-25 
erol utilisation in this study by making adaptive evolutionary engineering. The 26 
evolved strains exhibited improvements in all investigated parameters with up to 27 
148% increased growth rate, 57% increased final cell density and 11% reduction of 28 
lag phase. In five out of six evolved lineages we observed genomic alterations in the 29 
roxS gene indicating its importance in improved glycerol capabilities. Furthermore, 30 
we demonstrate that glycerol can support surface-associated biofilm formation. This 31 
study point towards using glycerol as a low cost feedstock for both planktonic and 32 
biofilm based production platforms. 33 
 34 
 35 
Introduction	  36 
A lot of effort is being made in order to reduce the extensive use of fossil fuels. Dif-37 
ferent alternatives to these resources are being considered for the purpose of replacing 38 
them with sustainable feedstocks. In recent years biodiesel has become an established 39 
alternative to conventional fuels as it can be used in conventional diesel engines with 40 
little or no major modifications (Johnson and Taconi, 2007).  41 
 3 
Production of biodiesel generates crude glycerol as a waste product accounting 42 
around 10 wt% of the produced biodiesel (Johnson and Taconi, 2007). This has re-43 
sulted in a major increase of crude glycerol as the biodiesel production has continued 44 
to increase. The concomitant accumulation of crude glycerol has made it an attractive 45 
low cost substrate for microbial cell factories (da Silva et al., 2009). The use of crude 46 
glycerol as a feedstock is however associated with challenges as it contains various 47 
impurities such as methanol, salt ions and heavy metals from the transesterification 48 
reaction which hampers microbial growth (da Silva et al., 2009, Hu et al., 2012, Fu et 49 
al., 2015). Nonetheless, the use of crude glycerol as an alternative feedstock will im-50 
prove the cost compatibility of biodiesel as well as the biochemicals produced by the 51 
microbial cell factories (Johnson and Taconi, 2007).  52 
The applicability of crude glycerol as a feedstock has been investigated in various 53 
studies (Fu et al., 2015, Verhoef et al., 2014, Fu et al., 2014). Some organisms are 54 
able to cope with the challenges associated to the present impurities in crude glycerol 55 
while other organisms are severely hampered. For example, Verhoef et al. (2014) 56 
showed that Pseudomonas putida is particularly tolerant towards the impurities in 57 
crude glycerol. In addition to this P. putida also possess high tolerance toward various 58 
solvents which is beneficial in connection to microbial production of biochemicals 59 
(Poblete-Castro et al., 2012). Furthermore, P. putida can grow in surface-associated 60 
biofilm which offers an alternative to the conventional bioreactor systems (Rosche et 61 
al., 2009). This mode of growth is known to be more tolerant towards toxic com-62 
pounds than the planktonic mode of growth (Li et al., 2006).  63 
These characteristics suggest that P. putida is a potentially attractive candidate in 64 
connection to biofilm-based cell factories that use crude glycerol as feedstock. The 65 
challenge of using glycerol is the limited knowledge on glycerol metabolism in P. 66 
 4 
putida. Furthermore, the use of glycerol is associated with both low growth rate and 67 
long lag phase (Nikel et al., 2014). This is a major limitation in exploiting this com-68 
pound. Hence, in this study we sought to improve P. putida growth on glycerol. This 69 
was achieved by employing adaptive laboratory evolution (Meijnen et al., 2008). In 70 
this study six lineages of P. putida was evolved which all had a significantly in-71 
creased growth rate. The evolved strains were genome sequenced and the mutations 72 
identified. We evaluated the use of glycerol as an alternative substrate for both plank-73 
tonic and biofilm cultivation. Since the composition of crude glycerol can vary de-74 
pending on origin of production (Thompson and He, 2006, Hu et al., 2012) reagent 75 
grade glycerol was used in this study in order to ascribe the observations to the glyc-76 
erol metabolism without being influenced by the contaminants.  77 
 78 
Results	  79 
Pseudomonas	  putida	  forms	  biofilms	  when	  cultivated	  on	  glycerol	  80 
Biofilm as a production platform have attracted increasing attention in recent years 81 
(Qureshi et al., 2005, Rosche et al., 2009). So far, Pseudomonas putida biofilm for-82 
mation has primarily been investigated in rich media or using citrate as carbon source 83 
(Gjermansen et al., 2010, Yousef-Coronado et al., 2011, Lopez-Sanchez et al., 2013). 84 
To expand the usability of glycerol as a low cost feedstock in connection to biofilm 85 
based cell factories, we investigated the ability of glycerol to sustain biofilm for-86 
mation. To this end, we monitored biofilm development in situ of P. putida KT2440 87 
using both citrate and glycerol as carbon source (Figure 1). By comparing glycerol 88 
grown biofilm and citrate grown biofilm it is evident that glycerol can support biofilm 89 
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growth. Initially, less biofilm biomass was present on glycerol compared to citrate, 90 
but on the second day comparable amount of biomass was reached.  91 
 92 
Evolution	  of	  glycerol-­‐adapted	  Pseudomonas	  putida	  variants	  93 
To improve glycerol utilisation of P. putida an adaptive evolution experiment was 94 
performed. Initial experiments were made in order to determine a suitable minimal 95 
medium. Based on these results MOPS minimal medium was favoured compared to 96 
AB10 and MSN minimal media (see Materials and methods), since this medium sup-97 
ported high growth rate, more homogeneous cultures and higher cell densities (Figure 98 
2). Different concentrations of glycerol were also explored. We chose the highest 99 
concentration of glycerol at which growth rate was not severely disturbed (Figure 2A) 100 
in order to achieve high cell densities at the end of growth (Figure 2B). Based on the-101 
se preliminary studies the MOPS minimal medium supplemented with 3% glycerol 102 
was chosen for the adaptive evolution experiment. 103 
Six parallel linages were prepared from single colonies and propagated by serial 104 
transfers into fresh medium generating approximately 700 generations of evolved 105 
strains. This experimental approach was chosen, as limited knowledge is present on 106 
glycerol metabolism in P. putida. From each of the evolved lineages a single colony 107 
was chosen for characterisation and genome sequencing. It was evident that all six 108 
lineages had adapted to glycerol utilisation by improving various parameters. As 109 
listed in Table 2 all evolved strains had increased growth rate, higher final cell density 110 
and a shorter lag phase. Importantly, all of these parameters were significantly im-111 
proved in the evolved strains demonstrating the feasibility of this approach to improve 112 
glycerol utilisation of P. putida. The enhanced growth rate observed in the evolved 113 
strains is approaching the growth rate in rich medium such as LB (in LB µ is 1.7 h-1).  114 
 6 
We next sought to elucidate the genomic alterations underlying these improvements 115 
in growth. Whole-genome sequencing of six variants (one from each of the six 116 
evolved lineages) enabled the identification of nucleotide substitutions and inser-117 
tions/deletions that accumulated during the experiment (Table 3). Overall, we found 118 
between three and five genomic alterations per variant strain (Table 3). Importantly, 119 
the genomic analysis revealed several examples of the same genes acquiring muta-120 
tions in multiple lineages. Such example of parallel evolution is a strong indicator that 121 
the mutations are beneficial in the particular selective environment. Especially, the 122 
roxS gene is interesting as five out of six lineages have alterations in this gene. Three 123 
lineages had a six base pair deletion, one with two base pair substitution and one with 124 
a single base pair substitution. Hence, this gene seems to be very important in mediat-125 
ing the observed improvements (Table 2).  126 
	  127 
Discussion	  128 
Glycerol metabolism is not well known in P. putida. Since this compound is an abun-129 
dant low cost substrate we wanted to investigate the applicability of glycerol as a 130 
feedstock. Crude glycerol has been used in various studies for producing biochemi-131 
cals (Fu et al., 2014, Verhoef et al., 2014). However, growth on glycerol is slow com-132 
bined with long lag phase making its use cumbersome (Nikel et al., 2014). In this 133 
study we have improved the growth on glycerol and explored the usability of glycerol 134 
for both planktonic growth as well as biofilm growth.  135 
The increasing knowledge of biofilm formation has made it an attractive candidate for 136 
industrial applications. Recently several studies have been published on using biofilm 137 
as the production platform for biochemicals (Gross et al., 2010, Li et al., 2006). The 138 
 7 
studies on biofilm formation primarily use rich media, glucose or citrate as the carbon 139 
source. For achieving cost competitive biochemicals produced from biofilm we have 140 
explored the use of glycerol as the substrate. We were able to demonstrate that glyc-141 
erol can support P. putida biofilm growth. The biomass of the established biofilm is 142 
comparable to that of citrate (Figure 1).  143 
 144 
Glycerol	  evolved	  Pseudomonas	  putida	  strains	  	  145 
In order to improve growth on glycerol we made an adaptive evolution experiment in 146 
this study. The evolved strains clearly had a growth advantage compared to the refer-147 
ence strain (Table 2). In addition to their increased growth rate the evolved lineages 148 
all had a higher final cell density. This indicates better utilisation of the substrate.  149 
The identified mutations resulting in the altered changes point toward parallel evolu-150 
tion. Many of the same genes were mutated in several lineages. The roxS seems to be 151 
very important in adapting to glycerol. It encodes a sensor histidine kinase which is 152 
part of a two component system together with a response regulator (PP_0888) placed 153 
downstream of the locus. Since it is part of a regulatory system changes in the func-154 
tionality will result in pleiotropic effects. The RoxS/RoxR regulon have been shown 155 
to be involved in various process such as metabolism and respiratory responses 156 
(Fernandez-Pinar et al., 2008). In particular it has been shown as a key sen-157 
sor/regulator of the redox state in P. putida (Fernandez-Pinar et al., 2008).  158 
The SMART analysis was employed to locate the mutations in order to determined if 159 
they are present in any domains. The deletion, which occurs in 3 lineages, is placed 160 
upstream of the histidine kinase domain which also is the case of the two base pair 161 
substitution lineage (VWgly5). In the last lineage (VWgly7) the mutation results in an 162 
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amino acid substitution inside of the histidine kinase domain. This may result in al-163 
tered functionality and result in conformational changes.  164 
Mutation in the lapA gene appears in two of the lineages. This gene encodes a surface 165 
adhesion protein which is involved in biofilm formation. Interestingly, this mutation 166 
appears in the only lineage (VWgly4) which does not contain any alterations in the 167 
roxS gene. In fact lineage VWgly7 having both roxS and lapA mutations is the lineage 168 
with the lowest growth rate whereas VWgly4 has a significantly higher growth rate 169 
(P<0.05) and is among the highest achieved.  170 
 171 
Glycerol	  as	  a	  substrate	  for	  biofilm	  development	  172 
The glycerol evolved strains exhibit significant improvements in planktonic growth 173 
compared to the reference strain. However, the mutations given rise to the improve-174 
ments may not be beneficial for supporting biofilm growth. Fernandez-Pinar et al. 175 
(2008) show that biofilm capabilities of a roxS mutant is highly dependent on the sub-176 
stratum. They observed a significantly lowered biofilm formation on corn seeds by a 177 
roxS mutant but this difference was abolished on an abiotic surface. Hence, the choice 178 
of substratum will be critical for establishing biofilm of the glycerol evolved strains. 179 
Interestingly, one of the lineages (VWgly7) harbours a mutation in the lapA gene to-180 
gether with roxS. The lapA gene encodes a large adhesive protein involved in biofilm 181 
formation. Gjermansen et al. (2010) showed that a lapA mutant is unable to produce 182 
biofilm. Since either a roxS or lapA mutation is apparent in all of the glycerol evolved 183 
lineages, the use of these strains as a biofilm platform could be impossible if not the 184 
surface is carefully selected.  185 
The presence of these mutations indicates that the enhanced growth abilities on glyc-186 
erol may come with the cost of impaired biofilm formation capabilities. One possibil-187 
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ity of circumventing this hurdle could be by using an appropriate abiotic substratum. 188 
However, this needs to be elucidated. Interestingly, none of the observed mutation 189 
appeared in the glp regulon which is important in glycerol metabolism (Nikel et al., 190 
2014). Since mutations in regulatory genes, such as roxS, results in pleiotropic chang-191 
es the molecular mechanism remains to be elucidated. Nonetheless, the changes 192 
somehow result in enhanced glycerol metabolism.  193 
 194 
Conclusions	  195 
The results presented in this study show that glycerol can successfully be used as a 196 
substrate for both planktonic and biofilm growth. By using adaptive evolution we 197 
were able to evolve strains capable of utilising glycerol to a much better extent than 198 
the reference strain. The enhanced performance on glycerol does however seems to 199 
come on the expense of biofilm impairments. Further characterisations of the glycerol 200 
evolved strains is needed for definite conclusions.  201 
 202 
Materials	  and	  methods	  203 
Strains	  and	  growth	  condition	  204 
The growth performance of Pseudomonas putida KT2440 was evaluated in the fol-205 
lowing minimal media: AB10, minimal salt medium (MSM) and morpholinepropane-206 
sulfonic acid (MOSP) buffered medium (Nielsen et al., 2000, Deziel et al., 2003, 207 
Jensen and Hammer, 1993). These media were supplemented with different concen-208 
trations of reagent grade glycerol (Sigma-Aldrich). The optimal medium was deter-209 
mined as MOSP medium supplemented with 3% glycerol. This was used for the adap-210 
tive laboratory evolution experiment.  211 
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The evolution experiment was made in six parallel linages each started from a single 212 
colony. The linages were serial transferred each day from an over night culture dilut-213 
ed 100 fold into fresh MOPS medium supplemented with 3% glycerol for 15 weeks. 214 
This resulted in approximately 700 generations of evolution. A single colony from 215 
each of the evolved lineages was isolated for growth characterisation and whole-216 
genome sequencing. 217 
Growth experiments were made in shake flasks and in microtiter dishes (TPP Techno 218 
Plastic Products AG). The optimal minimal media and glycerol concentration was de-219 
termined in shake flask experiments by diluting the over night cultures to a start 220 
OD600 of 0.01. The glycerol evolved strains were grown in MOPS medium supple-221 
mented with 3% glycerol. Over night cultures were diluted to OD600 of 0.001 and dis-222 
tributed into microtiter dishes and sealed with a permeable membrane (Breathe-Easy, 223 
Sigma-Aldrich). The microtiter dish growth experiment was made in Cytation 5 imag-224 
ing reader (BioTek, Holm & Halby, Denmark). The temperature was set to 30°C with 225 
continues shaking (3 mm) and OD600 measurements every 5 min.  226 
For visualising biofilm growth in situ the strains were chromosomally tagged at an 227 
intergenic neutral locus with gfp in a mini-Tn7 construct as described by Koch et al. 228 
(2001). The employed strains are listed Table 1.  229 
 230 
Genome	  sequencing	  	  231 
The glycerol evolved strains were genome sequenced to identify the alterations which 232 
have resulted in the increased growth rate. Single colonies from the evolved strains 233 
were isolated and used for genome sequencing. Genomic DNA was extracted using 234 
Wizard Genomic DNA Purification Kit (Promega). Library preparation and DNA se-235 
quencing (paired end) was made by Beijing Genomics Institute (BGI) in Hong Kong.  236 
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 237 
Data	  analysis	  238 
Data analysis of the sequenced genomes was made in CLC genomic workbench (Aar-239 
hus, Denmark). The paired end reads were mapped to the reference genome (acces-240 
sion number: NC_02947) using the default settings. Variant calling was made to the 241 
reference genome followed by comparison of the evolved glycerol strains to the refer-242 
ence strain used for the adaptive laboratory evolution experiments. The default pa-243 
rameters were used for variant calling. The determined single nucleotide polymor-244 
phisms and insertion/deletion were filtered to remove alterations which did not appear 245 
in both forward and reverse reads.  246 
 247 
Biofilm	  cultivation	  in	  flow	  chambers	  248 
Biofilm cultivation was made in three-channel flow chambers with individual channel 249 
dimensions of 1×4×40 mm covered with a glass cover slide (Knittel 24x50mm). The 250 
glass cover slide served as substratum for biofilm formation. The system was pre-251 
pared and assembled as described by Tolker-Nielsen and Sternberg (2011). Overnight 252 
cultures were made in modified FAB medium (Heydorn et al., 2000) supplemented 253 
with 5 mM glycerol or sodium citrate. Over night cultures were diluted to OD600 of 254 
0.010 and 500 µL of the diluted culture was injected into the channels. The flow 255 
chambers were turned upside down for 1 h to allow bacterial attachment without flow. 256 
The biofilm system was incubated at 22°C with modified FAB medium supplemented 257 
with 0.5 mM glycerol or sodium citrate. A laminar flow rate of 3 mL/h obtained by a 258 
Watson Marlow 205S peristaltic pump.  259 
 260 
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Microscopy	  and	  image	  processing	  	  261 
The biofilm formation was followed in situ using a Leica TCS SP5 confocal laser 262 
scanning microscope equipped with detectors and filters set for monitoring Gfp fluo-263 
rescence. Biofilm was magnified by a 63x/1.20 water objective. Biofilm images were 264 
acquired at the specified time points at a random position at a distance of 5-10 mm 265 
from the inlet of the flow channels. Three-dimension images were generated using the 266 
Imaris software package (Bitplane AG).  267 
 268 
Figures	  269 
 270 
                                 Citrate                           Glycerol 
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Figure 1. Biofilm formation of the reference strain P. putida grown on citrate or glyc-271 
erol as the carbon source. Depicted are representative pictures of biofilms from the 272 
specified days. The scale bar indicates the size of 50 µm.  273 
 274 
 275 
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 276 
Figure 2. Comparison of growth rate and cell density in different media. The growth 277 
rate (A) and highest obtained OD600 (B) of P. putida was compared in three different 278 
minimal media MOPS (circle), MSM (square) and AB10 (triangle) with varying con-279 
centration of glycerol. The growth experiment was made in shake flasks.  280 
 281 
Tables	  	  282 
Table 1. Strains and plasmids used in this study.  283 
Strain and plasmids Relevant characteristics Reference 
Strains   
 P. putida  Bagdasarian et al. 
(1981)  
Plasmids   
 pBK-miniTn7-gfp2  Gmr; PrnB P1gfpAGA 
Delivery vector for miniTn7-gfp2 
Koch et al. (2001) 
 pRK600 Cmr; oriColE1 RK2-mob+ RK2-tra+  
Helper plasmid in mating 
Kessler et al. (1992) 
 pUX-BF13 Apr; mob+ oriR6K  
Helper plasmid providing Tn7 transposition function in 
trans 
Bao et al. (1991) 
 284 
 285 
Table 2. Growth parameters from microtiter dish cultivation. The stated values are 286 
average and standard deviation of six technical replicates. All parameter are signifi-287 
cantly (P<0.05) different from the reference strain P. putida KT2440.  288 
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Strain µ (h-1) Max OD600 Lag phasea (h) 
P. putida KT2440 0.48 ± 0.06 0.30 ± 0.01 16.46 ± 0.34 
VWgly2 1.13 ± 0.11 0.47 ± 0.02 15.16 ± 0.11 
VWgly3 1.00 ± 0.10 0.47 ± 0.02 16.01 ± 0.32 
VWgly4 1.15 ± 0.02 0.45 ± 0.01 14.65 ± 0.23 
VWgly5 1.19 ± 0.07 0.47 ± 0.01 14.57 ± 0.07 
VWgly6 1.12 ± 0.17 0.45 ± 0.02 15.48 ± 0.52 
VWgly7 0.96 ± 0.12 0.44 ± 0.01 15.04 ± 0.86 
a The lag phase was determined as ceased if OD600 reached above 0.01. This value was chosen as low 289 
OD600 are subjected to fluctuations.  290 
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Table 3. List of mutations in the glycerol evolved strains compared to the reference strain.  291 
 
Region Type Referencea Alleleb Gene numberc Gene name AA change Non-synonymous (Yes/No) 
VWgly2 1030228..1030233 Deletion CCTGCG - PP_0887  roxS Ala96_Arg98 Y 
 
1474892 SNV T C IR 
   
 
4618828 SNV C T IR 
   
 
5537487 SNV G A PP_4870 
 
Ser29Leu Y 
 
6029588 SNV C G IR 
  
  
VWgly3 1030228..1030233 Deletion CCTGCG - PP_0887  roxS Ala96_Arg98 y 
 
1067413 SNV C T PP_0925 
 
Ala219Val Y 
 
3698879 SNV A T PP_3264 
 
Leu264Gln Y 
  5394274 SNV G A PP_4740 hsdR   N 
VWgly4 219529 SNV G A PP_0168  lapA Glu8346Lys Y 
 
4809961 SNV G A PP_4235 dsbD-2 Gly506Asp Y 
 
5681407^5681408 Insertion - CGGGG IR 
   
 
6029588 SNV C G IR 
  
  
VWgly5 699720 SNV A G IR     
 
 
1030180..1030181 MNV AC CT PP_0887 roxS 
 
N 
 
2159376 SNV A C PP_1916 fabF Thr121Pro Y 
  5681407^5681408 Insertion - CGGGG IR     
 VWgly6 1030228..1030233 Deletion CCTGCG - PP_0887  roxS Ala96_Arg98 Y 
 
5681407^5681408 Insertion - CGGGG IR 
     6029588 SNV C G IR       
VWgly7 219529 SNV G A PP_0168  lapA Glu8346Lys Y 
 
1030683 SNV G T PP_0887 roxS Gly248Val Y 
 
3717303 SNV G A PP_3282 paaC Pro165Ser Y 
 16 
  6029614 SNV G C IR       
a The nucleotide(s) in the reference strain which have changed. b The changed nucleotide(s) in the evolved strains. c IR, intergenic region. 292 
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Abstract	  
	  
Microbial	  activities	  are	  most	  often	  shaped	  by	  interactions	  between	  co-­‐existing	  microbes	  
within	  mixed-­‐species	  communities.	  Dissection	  of	  the	  molecular	  mechanisms	  of	  species	  
interactions	  within	  communities	  is	  a	  central	  question	  in	  microbial	  ecology,	  and	  our	  ability	  to	  
engineer	  and	  control	  microbial	  communities	  depend	  to	  a	  large	  extent	  on	  our	  knowledge	  of	  
these	  interactions.	  This	  review	  highlights	  the	  recent	  advances	  in	  relation	  to	  molecular	  
characterization	  of	  microbe-­‐microbe	  interactions	  that	  modulate	  community	  structure,	  
activity	  and	  stability,	  and	  aims	  to	  illustrate	  how	  these	  findings	  have	  helped	  reaching	  an	  
engineering-­‐level	  understanding	  of	  microbial	  communities	  in	  relation	  to	  both	  human	  health	  
and	  industrial	  biotechnology.	  	  
	  
Main	  text	  
	  
Most	  microbial	  species	  are	  embedded	  within	  ecological	  communities	  containing	  many	  
species	  that	  interact	  with	  one	  another	  and	  their	  physical	  environment.	  Virtually	  all	  
important	  microbial	  activities	  are	  shaped	  by	  interactions	  between	  co-­‐existing	  microbes	  
within	  mixed-­‐species	  communities.	  These	  interactions	  (e.g.	  in	  the	  form	  of	  physical,	  chemical	  
and	  genetic	  signals	  such	  as	  cell-­‐cell	  contact	  [1],	  metabolite	  exchange	  [2]	  and	  horizontal	  gene	  
transfer	  [3]	  control	  synergistic,	  antagonistic	  or	  neutral	  relationships	  among	  the	  interacting	  
partners,	  and	  are	  thus	  responsible	  for	  overall	  community	  properties	  such	  as	  species	  
composition	  and	  function.	  In	  addition,	  microbial	  interactions	  may	  be	  dynamic	  and	  
dependent	  on	  environmental	  context,	  and	  microbial	  communities	  can	  have	  different	  spatial	  
interactive	  distributions	  ranging	  from	  metabolic	  interactions	  between	  unassociated	  
planktonic	  cells	  in	  the	  ocean	  [4]	  and	  long-­‐distance	  electrical	  signalling	  within	  microbial	  
communities	  [5,	  6]	  to	  local	  cell-­‐cell	  interactions	  occurring	  within	  surface-­‐attached	  biofilms	  
[7].	  Furthermore,	  a	  series	  of	  recent	  studies	  have	  shown	  that	  microbe-­‐microbe	  and	  microbe-­‐
host	  interactions	  can	  also	  be	  mediated	  by	  small,	  air	  transmittable	  molecules	  [8-­‐10].	  
Given	  this	  complexity	  among	  microbial	  interactive	  processes,	  it	  remains	  a	  central	  challenge	  
to	  improve	  our	  understanding	  of	  both	  the	  molecular	  mechanisms	  underlying	  these	  
interaction	  processes,	  their	  combinatorial	  effects,	  and	  how	  these	  interactions	  ultimately	  
modulate	  diversity,	  behaviours	  and	  activities	  of	  the	  individual	  species	  within	  complex	  
microbial	  communities.	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Dissection	  of	  the	  molecular	  mechanisms	  of	  species	  interactions	  within	  communities	  is	  an	  
important	  question	  in	  microbial	  ecology.	  Recently,	  studies	  of	  a	  diverse	  range	  of	  microbial	  
ecosystems	  have	  provided	  new	  insight	  into	  this	  area	  by	  combining	  omics	  methods	  with	  
classical	  microbiology	  cultivation	  techniques.	  These	  systems	  include	  multi-­‐species	  microbial	  
communities	  formed	  during	  production	  of	  fermented	  food	  [11,	  12],	  microbial	  communities	  
in	  acid	  mine	  drainages	  and	  other	  polluted	  habitats	  [13],	  the	  commensal	  microbiota	  of	  corals	  
[14],	  as	  well	  as	  several	  other	  ecosystems.	  In	  this	  review,	  we	  focus	  primarily	  on	  studies	  of	  
microbe-­‐microbe	  interactions	  in	  host-­‐associated	  microbial	  communities	  and	  in	  relation	  to	  
engineering	  of	  mixed-­‐species	  microbial	  cell	  factories.	  We	  use	  these	  two	  examples	  to	  broadly	  
illustrate	  and	  discuss	  how	  knowledge	  of	  species	  interactions	  is	  of	  importance	  in	  relation	  to	  
our	  ability	  to	  control	  and	  utilize	  microbial	  systems.	  	  
	  
Advances	  in	  studies	  of	  pathogen-­‐microbiota	  interactions.	  	  
In	  relation	  to	  infectious	  diseases,	  it	  is	  becoming	  increasingly	  clear	  that	  interactions	  between	  
bacterial	  pathogens	  and	  other	  microbial	  species	  present	  at	  the	  infection	  site	  (for	  example,	  
co-­‐infecting	  pathogens	  or	  commensal	  bacteria)	  can	  influence	  disease	  phenotype	  or	  clinical	  
outcome.	  One	  example	  of	  the	  importance	  of	  such	  pathogen-­‐microbiota	  interactions	  is	  the	  
well-­‐established	  role	  of	  the	  intestinal	  commensal	  microbiota	  in	  relation	  to	  prevention	  of	  
colonization	  of	  invading	  microorganisms	  including	  bacterial	  pathogens	  in	  a	  process	  known	  as	  
colonization	  resistance	  [15].	  The	  ability	  to	  characterize	  microbial	  community	  structures	  using	  
16S	  rRNA-­‐based	  phylogenies	  or	  full	  metagenomic	  sequencing	  has	  now	  resulted	  in	  a	  much	  
deeper	  understanding	  of	  the	  interplay	  between	  the	  human	  microbiome	  and	  bacterial	  
pathogens	  in	  relation	  to	  infectious	  disease	  development.	  For	  example,	  studies	  of	  the	  
microbial	  communities	  in	  certain	  chronic	  infections	  such	  as	  cystic	  fibrosis	  (CF)	  have	  revealed	  
clear	  correlations	  between	  loss	  of	  community	  diversity	  and	  disease	  progression	  [16-­‐18].	  CF	  
patients	  are	  predisposed	  to	  airway	  infections	  from	  a	  number	  of	  bacterial	  opportunistic	  
pathogens,	  among	  which	  Pseudomonas	  aeruginosa,	  Staphylococcus	  aureus,	  Haemophilus	  
inﬂuenzae,	  and	  Burkholderia	  cepacia	  complex	  (BCC)	  have	  been	  directly	  associated	  with	  the	  
CF	  lung	  disease	  [19-­‐21].	  However,	  recent	  studies	  based	  on	  culture-­‐independent	  methods	  
have	  demonstrated	  the	  presence	  of	  many	  additional	  bacterial	  species	  previously	  undetected	  
by	  culture	  and	  have	  revealed	  a	  greater	  microbial	  diversity	  in	  the	  CF	  airways	  than	  previously	  
recognized	  [20].	  The	  CF	  airways	  clearly	  represent	  a	  complex	  and	  diverse	  polymicrobial	  
ecosystem,	  and	  as	  the	  disease	  symptoms	  become	  more	  severe,	  the	  CF	  lung	  microbiota	  
becomes	  dominated	  by	  the	  primary	  pathogen	  (which	  most	  often	  is	  the	  opportunistic	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pathogen	  Pseudomonas	  aeruginosa)	  [16-­‐18].	  These	  results	  are	  suggestive	  of	  a	  wider	  role	  of	  
the	  respiratory	  microbiota,	  and	  highlight	  the	  importance	  of	  interactions	  between	  the	  
primary	  pathogen	  and	  the	  microbiota	  in	  relation	  to	  disease	  progression.	  	  
There	  are	  several	  recent	  and	  parallel	  examples	  of	  interactions	  between	  the	  commensal	  
microbiota	  and	  possible	  pathogens	  which	  are	  responsible	  for	  limiting	  colonization	  and	  
infections	  by	  bacterial	  pathogens	  such	  as	  Staphylococcus	  aureus	  in	  the	  nasal	  cavity	  [22],	  and	  
enteropathogenic	  Escherichia	  coli	  [23],	  and	  Vibrio	  cholera	  [24]	  in	  the	  gut.	  Despite	  these	  
exciting	  observations,	  we	  are	  still	  far	  from	  being	  able	  to	  efficiently	  harness	  the	  protective	  
capability	  of	  the	  commensal	  microbiota	  against	  pathogens.	  Nevertheless,	  these	  and	  related	  
findings	  clearly	  point	  toward	  chemical	  and/or	  biological	  interference	  with	  microbial	  
interaction	  networks	  within	  diseased	  hosts	  as	  alternative	  treatment	  strategies	  against	  
pathogens.	  	  
	  
The	  findings	  mentioned	  above	  highlight	  the	  importance	  of	  research	  aimed	  at	  systematic	  
mapping	  of	  interspecies	  interactions	  in	  relation	  to	  different	  types	  of	  bacterial	  infections,	  in	  
combination	  with	  identification	  and	  molecular	  characterization	  of	  these	  interactions.	  In	  
other	  words,	  it	  is	  now	  critical	  to	  move	  beyond	  correlative	  research	  and	  studies	  focused	  on	  
generating	  microbiome	  ‘parts’	  lists,	  and	  instead	  begin	  to	  focus	  on	  causality	  and	  function	  at	  
the	  molecular	  level.	  Indeed,	  a	  few	  pioneering	  studies	  have	  recently	  illustrated	  these	  points	  
very	  clearly,	  and	  there	  are	  now	  clear	  examples	  of	  identified	  microbe-­‐microbe	  interactions	  
mediated	  by	  bacterial	  metabolites	  and	  gene	  products	  that	  function	  either	  to	  limit	  pathogen	  
colonization	  [22-­‐25]	  or	  potentiate	  pathogen	  expansion	  or	  virulence	  [26-­‐28].	  Although	  it	  is	  
obviously	  challenging	  to	  identify	  and	  characterize	  microbial	  interspecies	  interactions	  in	  
infected	  hosts,	  interdisciplinary	  approaches	  that	  combines	  classical	  microbiological	  in	  vitro	  
cultivation	  techniques	  with	  advancing	  technologies	  such	  as	  three-­‐dimensional	  (3D)	  printing	  
[29],	  imaging	  mass	  spectrometry	  [28,	  30],	  and	  development	  of	  realistic	  and	  controllable	  in	  
vitro	  model	  systems	  [31],	  now	  makes	  it	  possible	  to	  begin	  to	  systematically	  tease	  apart	  the	  
interactions	  among	  cultivated	  key	  community	  members,	  and	  to	  determine	  how	  these	  
interactions	  modify	  pathogen	  behaviors.	  	  	  
	  
Engineering	  synthetic	  multispecies	  communities	  for	  bioproduction	  purposes.	  	  
In	  Nature,	  microbes	  form	  interacting	  mixed-­‐species	  communities	  to	  accomplish	  complex	  
chemical	  conversions	  through	  division	  of	  labor	  among	  the	  individual	  organisms.	  We	  have	  
successfully	  harnessed	  the	  power	  of	  such	  natural	  microbial	  communities	  in	  food	  and	  other	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industries	  for	  decades	  [32,	  33],	  and	  this	  has	  logically	  led	  to	  the	  emerging	  concept	  of	  
community-­‐based	  cell	  factories	  in	  which	  synthetic	  microbial	  communities	  are	  rationally	  
designed	  and	  engineered	  to	  produce	  valuable	  chemicals.	  Recent	  studies	  have	  indeed	  
demonstrated	  the	  potential	  value	  of	  such	  engineered	  mixed-­‐species	  communities	  as	  
production	  platforms.	  In	  one	  recent	  example,	  a	  synthetic	  mixed-­‐species	  community	  of	  
Escherichia	  coli	  and	  Saccharomyces	  cerevisiae	  was	  engineered	  to	  produce	  complex	  
pharmaceutical	  molecules	  including	  precursors	  of	  the	  anti-­‐cancer	  drug	  paclitaxel	  [34].	  By	  
engineering	  the	  two	  organisms	  to	  host	  specific	  portions	  of	  the	  biosynthetic	  pathways,	  it	  was	  
possible	  to	  construct	  a	  co-­‐culture	  system	  in	  which	  an	  intermediate	  metabolite	  was	  first	  
produced	  by	  E.	  coli	  and	  then	  further	  functionalized	  by	  S.	  cerevisiae	  to	  give	  the	  final	  product.	  
This	  study	  is	  the	  first	  demonstration	  of	  segregation	  of	  long	  and	  complex	  biosynthetic	  
pathways	  into	  separate	  organisms	  each	  carrying	  portions	  of	  the	  pathway,	  which	  not	  only	  
enable	  parallel	  optimization	  of	  the	  independent	  pathway	  modules,	  but	  also	  makes	  it	  
possible	  to	  use	  the	  best	  match	  between	  particular	  pathway	  modules	  and	  specific	  hosts.	  In	  
another	  recent	  study,	  a	  fungal-­‐bacterial	  community	  was	  engineered	  to	  convert	  
lignocellulosic	  biomass	  into	  biofuels	  [35].	  Here,	  the	  community	  contained	  the	  fungus	  
Trichoderma	  reesei,	  which	  can	  hydrolyse	  lignocellulosic	  biomass	  into	  soluble	  saccharides,	  
and	  the	  bacterium	  E.	  coli	  which	  can	  metabolize	  these	  saccharides	  into	  isopropanol.	  In	  this	  
example,	  one	  species	  only	  provided	  the	  carbon	  source	  for	  the	  second	  species,	  which	  in	  turn	  
was	  able	  to	  produce	  the	  final	  product	  on	  its	  own.	  	  
It	  is	  clear	  from	  these	  and	  other	  studies	  that	  successful	  engineering	  of	  community-­‐based	  
microbial	  cell	  factories	  rely	  greatly	  on	  our	  molecular	  understanding	  of	  microbe-­‐microbe	  
interactions,	  and	  how	  these	  influence	  community	  assembly,	  stability	  and	  activity.	  	  
	  
Controlling	  the	  stability	  of	  community-­‐based	  cell	  factories.	  	  
Unlike	  their	  natural	  counterparts,	  synthetic	  communities	  are	  often	  unstable.	  For	  example,	  
different	  growth	  rates	  among	  the	  constituent	  organisms	  and	  secretion	  of	  toxic	  metabolites	  
during	  growth	  can	  influence	  the	  stability	  of	  the	  community	  and	  will	  often	  lead	  to	  single-­‐
species	  domination	  or	  extinction	  of	  the	  community	  [36].	  This	  general	  instability	  of	  synthetic	  
communities	  limits	  their	  translation	  into	  real-­‐world	  applications	  in	  industrial	  biotechnology,	  
and	  achieving	  long-­‐term	  maintenance	  of	  synthetic	  communities	  is	  a	  significant	  challenge	  
that	  must	  be	  solved.	  	  
Although	  we	  still	  have	  incomplete	  understanding	  of	  the	  multiple	  competitive	  and	  
cooperative	  interactions	  that	  control	  microbial	  community	  assembly	  and	  activity,	  many	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different	  strategies	  have	  been	  successfully	  employed	  to	  increase	  the	  stability	  of	  synthetic	  
communities.	  In	  the	  first	  example	  described	  above,	  Zhou	  et	  al	  [34]	  used	  knowledge	  of	  the	  
metabolic	  capacities	  of	  the	  constituent	  organisms	  to	  construct	  a	  specific	  environment	  that	  
favoured	  community	  stability:	  E.	  coli	  can	  use	  xylose	  as	  carbon	  source,	  but	  when	  grown	  on	  
this	  carbon	  source,	  E.	  coli	  excretes	  acetate,	  which	  is	  inhibitory	  to	  its	  own	  growth.	  On	  the	  
other	  hand,	  S.	  cerevisiae	  can	  use	  acetate	  as	  carbon	  source	  but	  not	  xylose.	  The	  use	  of	  a	  
specific	  carbon	  source	  (in	  this	  case	  xylose)	  thus	  created	  a	  mutualistic	  interaction	  between	  
the	  two	  organisms,	  which	  in	  turn	  stabilized	  the	  community.	  	  
In	  the	  other	  mixed-­‐species	  community	  (containing	  T.	  reesei	  and	  E.coli)	  described	  in	  the	  
previous	  section,	  Minty	  et	  al	  [35]	  took	  advantage	  of	  the	  particular	  co-­‐operator/cheater	  
relationship	  that	  existed	  in	  their	  engineered	  fungal-­‐bacterial	  community,	  and	  used	  
ecological	  theory	  to	  establish	  specific	  conditions	  (in	  terms	  of	  population	  sizes)	  that	  could	  
stabilize	  this	  interaction.	  	  
However,	  community-­‐stabilizing	  culture	  conditions	  –	  similar	  to	  the	  ones	  described	  in	  these	  
two	  examples	  -­‐	  may	  be	  difficult	  to	  design	  and	  construct	  for	  other	  synthetic	  communities.	  
Most	  likely,	  it	  is	  reasonable	  to	  expect	  that	  alternative	  approaches	  will	  be	  required	  in	  most	  
other	  situations.	  These	  alternative	  methods	  may	  include	  construction	  of	  synthetic	  
interactions	  by	  genetic	  engineering	  of	  the	  participating	  species	  to	  enforce	  their	  interaction.	  
For	  example,	  genetic	  construction	  of	  pairs	  of	  auxotrophs	  that	  cross-­‐feed	  and	  support	  growth	  
of	  each	  other	  when	  co-­‐cultured	  has	  been	  shown	  to	  be	  an	  effective	  approach	  for	  
improvements	  of	  community	  maintenance	  [37,	  38].	  Other	  strategies	  have	  relied	  on	  
programming	  specific	  mutualistic	  interactions	  by	  means	  of	  synthetic	  intercellular	  signalling	  
circuits	  [39-­‐41].	  However,	  such	  synthetic	  interactions	  are	  of	  course	  also	  targets	  of	  
evolutionary	  process	  and	  the	  long-­‐term	  stability	  of	  these	  genetic	  modifications	  is	  currently	  
not	  well	  understood.	  	  
	  
Form	  and	  function	  in	  microbial	  communities.	  	  
A	  fundamental	  principle	  in	  biology	  is	  that	  structure	  (form)	  and	  function	  are	  inseparable	  
elements.	  For	  example,	  spatial	  separation	  of	  cells	  that	  are	  then	  subsequently	  linked	  together	  
through	  controlled	  proximity	  is	  an	  organizational	  theme	  frequently	  observed	  at	  all	  levels	  in	  
biology	  [42].	  In	  relation	  to	  natural	  microbial	  communities,	  it	  is	  well	  established	  that	  spatial	  
organization	  of	  the	  component	  species	  has	  significant	  impact	  on	  the	  function	  and	  activity	  of	  
the	  systems	  [43-­‐45].	  Interestingly,	  such	  structure/function	  considerations	  are	  often	  not	  
included	  in	  the	  design	  of	  synthetic	  microbial	  communities,	  or	  considered	  in	  relation	  to	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human	  infections	  where	  the	  spatial	  and	  dynamic	  distribution	  of	  bacteria	  (including	  
pathogens)	  and	  their	  activities	  within	  the	  human	  host	  has	  been	  found	  to	  be	  more	  complex	  
than	  previously	  realized	  [46-­‐48].	  	  
In	  relation	  to	  construction	  of	  community-­‐based	  cell	  factories,	  it	  is	  certainly	  a	  possibility	  that	  
alternative	  community-­‐stabilizing	  methods	  should	  build	  on	  knowledge	  of	  structure/function	  
relationships.	  Indeed,	  it	  has	  been	  shown	  that	  spatial	  separation	  and	  artificial	  positioning	  of	  
cells	  within	  synthetic	  microbial	  communities	  improves	  community	  function	  and	  stability	  
[36].	  Recent	  advances	  in	  fluidics-­‐based	  bacterial	  cultivation	  chambers	  [49],	  3D	  printing	  
methods	  [29],	  and	  other	  micro-­‐patterning	  techniques	  [50]	  represent	  exciting	  areas	  in	  this	  
direction	  that	  may	  advance	  our	  ability	  to	  efficiently	  design	  and	  control	  the	  spatial	  
organization	  of	  cells	  within	  microbial	  communities.	  	  
	  
Summary	  	  
As	  members	  of	  either	  infection	  communities	  within	  colonized	  hosts,	  or	  part	  of	  synthetic	  
communities	  for	  sustainable	  bioproduction,	  both	  pathogenic	  and	  industrial	  relevant	  bacteria	  
are	  placed	  in	  polymicrobial	  environments	  in	  which	  interactions	  and	  spatial	  position	  
modulates	  their	  activity.	  In	  both	  areas	  there	  is	  a	  clear	  need	  to	  move	  beyond	  the	  current	  
sequenced-­‐based	  technologies	  often	  used	  to	  characterize	  complex	  microbial	  communities,	  
and	  begin	  to	  identify	  and	  characterize	  the	  function	  of	  microbial	  interactions	  and	  the	  role	  of	  
spatial	  organization.	  The	  examples	  shown	  here	  illustrate	  that	  such	  knowledge	  can	  provide	  
new	  strategies	  for	  better	  control	  of	  bacterial	  infection	  and	  optimized	  utilization	  of	  
community-­‐based	  microbial	  cell	  factories.	  Finally,	  we	  emphasize	  that	  although	  our	  
discussion	  is	  focused	  on	  examples	  of	  multispecies	  bacterial	  systems	  in	  relation	  to	  disease	  
and	  biosynthesis,	  we	  believe	  these	  are	  indeed	  representative	  examples	  of	  an	  awakening	  
field	  within	  microbial	  ecology	  focused	  on	  understanding	  species	  interactions	  in	  many	  types	  
of	  polymicrobial	  ecosystems.	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